





Early intervention in a mouse model of childhood obesity: effects 
on brown adipose tissue function 
 
 






Submitted in partial fulfillment of the  
requirements for the degree of  
Doctor of Philosophy  
under the Executive Committee  








































Jaclyn S. Lerea 
All rights reserved 
ABSTRACT 
Early intervention in a mouse model of childhood obesity: effects on brown 
adipose tissue function 
Jaclyn S. Lerea 
Due to the high childhood obesity rates within the United States, it is necessary to 
develop efficacious strategies to combat childhood obesity.  To explore whether early 
intervention can produce lasting metabolic improvements, we used a mouse model of 
genetically-induced hypothalamic leptin resistance (LeprNkx2.1knockout, hereby known as 
KO) that exhibits early-onset hyperphagia and obesity.  We found that KO mice exhibit 
reduced capacity of the brown adipose tissue (as seen by disorganized mitochondrial 
structure).  Brown adipose tissue capacity can be restored by paired-feeding in the peri-
weaning period, leading to persistent improvements in later adiposity even after 
restriction ends.  These studies lead us to investigate the maturation process of brown 
adipose tissue in the peri-weaning period.  We found that brown adipose tissue expansion 
between 2 to 3 weeks of age is accompanied by a reduced thermogenic capacity in 
control mice, as determined by protein levels of uncoupling protein 1 and disorganization 
of the mitochondrial cristae.  Thermogenic function was restored by 5 weeks of age, as 
demonstrated by a peak of uncoupling protein 1, in control mice but not KO mice.  
Paired-feeding of KO mice in the peri-weaning period rescued this peak at 5 weeks of 
age.  These studies elucidate a critical period when brown adipose tissue expansion is 
followed by activation.  The magnitude of brown adipose tissue activation at this time 
might be predictive of future obesity and metabolic rate, highlighting a potential 
therapeutic time window in which to intervene in pediatric obesity. 
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CHAPTER 1: Background Overview 
Part I:  Epidemiology of Childhood Obesity 
Obesity prevalence within the United States 
Based on the 2011-2012 census, 34.9% of the adult population is obese, with over 
66% of the population being either obese or overweight (1).  The high prevalence of 
obesity during this timeframe is not limited to adults, as roughly 17% of children and 
adolescents are obese (2).  The high prevalence of childhood obesity may underlie the 
increased rates of early-onset obesity-associated comorbidities, such as type 2 diabetes, 
pulmonary and cardiovascular disorders, gastrointestinal disorders, and metabolic 
syndrome (3-7).  In an effort to battle the rise in childhood obesity and early-onset 
comorbidities, there has been an increase in obesity prevention programs geared towards 
adolescents.  If treated early, the metabolic abnormalities (i.e. blood pressure and lipid 
profiles) can resolve (5, 8) and result in long lasting improvements.  
 
Etiology of childhood obesity 
In order to identify the age at which intervention programs would be most 
effective, it is helpful to first consider when patterns of increased body weight in 
childhood might be established.  One way to approach this issue is to determine the age at 
which increased body mass index (BMI) and body weight during childhood are highly 
predictive of later adiposity.  Obesity at a very young age (1-2 years of age) is not 
predictive of becoming obese in young adulthood (odds ratio (OR) of 1.3, 95% 
confidence interval (CI) 0.6-3.0) (9), whereas children who are obese at 5 years of age are 
4-5 times more likely to maintain their obesity into eighth grade (10, 11).  If obese by 10-
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14 years of age, there is a 75% prevalence of staying obese into young adulthood (21-29 
years of age) (OR of 28.3, CI 15.0-53.5) (9).  These findings support the idea that 
increased BMI during early childhood leads to an increase in relative risk for obesity in 
adulthood (9, 12).   
While body weight during childhood is increasingly correlated with adult obesity, 
a high birth weight per se is not predictive of obesity in adulthood (9, 13, 14), as a 
heavier birth weight tracks with increased lean mass as opposed to fat mass (13).  
Similarly, body weight in infants 1-2 years old does not correlate with later adiposity (9, 
12).  However, three distinct patterns of growth in early childhood have been linked to 
later obesity risk: (i) rapid “catch-up” growth (13), (ii) early adiposity rebound (AR) (15), 
and (iii) the age of onset of peak height velocity (PHV) (7). 
(i) “Catch-up” growth.  This pattern of growth refers to the rapid weight gain after 
birth that often occurs in small for gestational age babies that received insufficient 
nutrition during fetal development (13, 16).  This rapid weight gain within the first 1-2 
years of life, as opposed to low birth weight per se, appears to be associated with later 
obesity (13, 16, 17).  These findings are supported by outcomes from several studies 
demonstrating that increased “catch-up” growth within the first few months of age is 
correlated with later adiposity (18-20).  “Catch-up” growth within the first year after birth 
coincides with the normal period of rapid adipose tissue expansion, which promotes 
increased BMI (21).  The rate of “catch-up” growth is also inversely associated with rates 
of energy expenditure (EE) in infants born to obese mothers (22), raising the possibility 
that early deficits in EE can contribute to later body weight gain.  
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(ii) Adiposity rebound.  After the first year of life, the rate of adipose tissue 
deposition declines as the child continues to grow in height, leading to steady reductions 
in BMI over the next several years (21).  The point at which body fat begins to increase 
again is called the adiposity rebound (AR) (21, 23, 24) (AR is illustrated in Figure 1.1).  
The average AR occurs at 6 years of age (21, 23, 24).  Children with an AR at 3 years of 
age are more likely to be obese by 21 years than those with an AR around 6 years of age 
(24).  This correlation has been shown to be independent of parental obesity and BMI at 
the onset of AR (23).  It is important to note that a child with increased BMI and a later 
AR will most likely stay obese as an adult (24), however most children with an early AR 
tend to have a normal BMI to start, and begin to increase body fat after AR begins (24).  
Early AR is associated with increased rate of maturity (24), and therefore “catch-up 
growth” and timing of AR are not necessarily related.  
 
	   	  
Figure 1.1.  Adiposity Rebound Curves.  X axis represents BMI (kg/m2).  Solid line 
represents early AR, dashed line represents late AR.  AR; Adiposity rebound. Graph 
adapted from information derived from Rolland-Cachera MF, Deheeger M, Maillot M, 
Bellisle F. Int J Obes. (2006).  Reference (24). 
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(iii) Peak height velocity (PHV).  PHV is defined as the time period of maximal 
growth rate (25).  PHV occurs on average at 11.5 years of age in girls and 13.5 years of 
age in boys (26).  Early-onset PHV is correlated with increased BMI and central 
adiposity (27), as well as metabolic syndrome in boys (7).  Early AR is often associated 
with an earlier PHV (28).  Therefore, obesity risk associated with PHV could also reflect 
earlier growth-related processes.  Blunting the rapid increase in body weight gain during 
AR represents a promising target for childhood obesity interventions (16, 20). 
 
Part II:  Current Efforts to Combat Pediatric Obesity in Humans 
Reason for implementing early intervention 
Weight loss is associated with changes in sympathetic nervous system (SNS) tone 
(29), subsequently driving the decreased EE that promotes weight regain (29, 30).  This 
phenomenon is also seen in adolescence, where lifestyle intervention results in a similar 
compensatory metabolic phenotype as seen in adults (31-33).  These observations support 
the idea that body fat baselines are established at an early age, prior to puberty.  Thus, 
interventions in teens are likely to face the same obstacles as in adults. 
 
Early intervention in humans 
Efforts to combat childhood obesity are increasingly focused on younger ages.  Results 
from several different types of intervention are summarized below. 
(i) Maternal control of food intake.  One of the simplest types of interventions is 
when a mother restricts the amount of food she will give to her young child during the 
first few years of life.  Maternal restriction of solid food during infancy, as well as 
restriction between 3-5 years of age, can influence later weight gain in females, as 
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children become disinhibited (34, 35) (as measured by food consumption in the absence 
of an appetite (35, 36)).  The level of disinhibition is correlated with the magnitude of 
restriction (36).  Conversely, pressure to eat more at this young age was associated with 
restrictive eating behavior later in life, resulting in reduced body weight (34).  Therefore, 
strategies to combat childhood obesity in young girls that involve caloric restriction may 
backfire due to undesired effects on the development of brain circuits regulating 
motivated aspects of feeding behavior. 
(ii) Community-based intervention programs targeting pediatric obesity.  A 
growing number of programs involving school-based, community-based and home-based 
intervention have been implemented to reduce the prevalence of childhood obesity (37-
39).  These programs have included increased physical activity, dietary restriction, and 
behavioral counseling/education, alone or in combination (40).  The High Five for Kids 
and LEAP 2 randomized control trails evaluated behavioral modification obesity 
prevention programs, using educational material given to the family and children and/or 
motivational interviewing of the family members, for children 2-10 years of age across 
different clinical practice groups (41, 42). These intervention trials resulted in no 
improvements in BMI, as the physical activity amount and nutritional choices did not 
change (41, 42).  This is reflected in the fact that 77.2% of children in the intervention 
group remained obese/overweight 12 months post-intervention in the LEAP 2 trial 
compared to the 82.6% of the control group remaining obese (difference of -5.4%, 95% 
CI; -15.5, 4.6. p=.29) (42).  Similarly, the High Five intervention trial participants only 
had changes in BMI of -0.21 kg/m2 (95% CI; -0.05, 0.07. p=.15) compared to the control 
group 12 months post-intervention (41).  When stratified by gender, there was a modest, 
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but significant difference in BMI in young girls (-.38; 95% CI; -0.73, -0.03. p=.03), 
which could be an artifact of overall family awareness of body weight or healthier 
lifestyles leading to further adherence to intervention (41).  These findings suggest that 
education alone is not enough to result in improvements in obesity related outcomes. 
One meta-analysis of intervention programs implemented in children between the 
ages of 5 and 16 years old showed that physical activity impacted percent body fat (-.4%; 
95% CI; -0.7, -0.1. p=.05, effect size; 9/369)  without changes in BMI (43).  Other meta-
analyses of physical activity intervention programs yielded inconsistent findings within 
the cohorts tested (-0.5%; 95% CI; -0.7, -0.3. p=.81, effect size 6/358) (44).  Differences 
could be due to the discrepancies in amount of physical activity, as there is a high 
correlation between the amount of exercise per week and the reductions in percent body 
fat (43).  Although it seems that physical activity could reduce adiposity during this time 
window in overweight and obese children, the evidence for long-term improvements in 
body weight, BMI, and central obesity in adulthood has been inconclusive (43). 
A meta-analysis of interventions involving only caloric restriction showed that it 
is ineffective in preventing future obesity (BMI change of -0.22; 95% CI -0.56, 0.22, NS) 
(44).  Combination therapy of physical activity and caloric intervention, however, 
resulted in BMI reduction, especially when there was parental involvement (BMI change 
of -0.64; 95% CI -0.88, -0.39, p value not reported) (44).  This is in contrast with a meta-
analysis performed by Peirson et al. (2015) who found that classroom-based intervention 
geared towards individual children resulted in significant changes in BMI compared to 
those with parental involvement (p=.007 between the two groups) (individual focus BMI 
change -0.9; 95% CI -1.27,-0.53. p<.001; Family focus BMI change -0.34; 95% CI -0.52, 
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-0.16. p= <.001), yet there was still a significance in both subgroups of intervention type 
(8).  Regardless of the individual versus family focus, Peirson et al. (2015) is in 
agreement with previous meta-analysis results, reporting that reductions in BMI as a 
result of exercise and diet (-1.09; 95% CI -1.84,-0.34. p<.001) are greater than when 
compared to diet (-0.36; 95% CI -0.65, -0.06. p=.27) and exercise (-.43; 95% CI -0.65,-
0.21. p=N/A) alone (8).  Unfortunately, many of these studies did not look at follow-up 
beyond the intervention.  Given the increased cost of healthcare for childhood obesity, it 
is important to determine the most cost-effective treatment (45).  Even reductions of 1% 
in BMI during childhood can make an impact on overall healthcare costs (46). 
 (iii) Age as a predictor of success.  Several groups examined whether age is a 
predictor of success in BMI reduction following weight loss intervention (47, 48).  
Although there was no significant correlation of age at which intervention is implemented 
and success of intervention, there was a trend towards increased effectiveness when 
intervention was implemented in children 8-10 years of age or younger (44, 49, 50).  In a 
separate study in 1291 children ranging from 8.5-13.5 years of age, it was found that 
extremely obese children who were less than 10 years of age had a greater BMI standard 
deviation score (SDS) (adjusted for child’s age and gender) (BMI-SDS) reduction (-
0.24  ±  0.38) than those over 10 years of age (-0.05  ±  0.30), which lasted 1 year post-
intervention (49).  Similarly, an outpatient lifestyle intervention program conducted in 
663 obese children aged 4-16 years old found that intervention in younger obese children 
resulted in the greatest reduction in BMI-SDS (50).  Children 4-7 years old had the 
highest rate of BMI-SDS reduction (-0.44±.04), followed by 8-10 year olds (-0.37±.05) 
and 11-12 year olds (-0.26±.05) during intervention (50).  However, 8-10 year olds had 
	   8	  
the lowest reduction in BMI-SDS 4 years post-intervention (-0.30±.05) compared to 4-7 
year olds (-0.50±.04) or 11-12 year olds (-.038±.05) (50).  This discrepancy can be 
explained by the onset of puberty that occurs within this age group (50).  The poorest 
prognosis for intervention success was in children aged 13-16 years old (-0.21±.06 
immediately post-intervention, -0.27±.05 4 years post-intervention) (50), consistent with 
the fact that obesity at 10-14 years of age is associated with increased relative risk of 
becoming obese in adulthood (9).   
Further supporting the idea of a critical time window for intervention around 10 
years of age was a study conducted in Sweden using a one-year intervention approach in 
children 8-13 years of age.  The study found that the one-year intervention program 
resulted in differential effects on weight maintenance; a subset of children regained the 
lost weight while others did not (51).  Weight maintenance versus regain was associated 
with changes in thyroid hormone (51), providing a possible biomarker of weight loss 
success in children.  Unfortunately, these studies did not look at EE changes in the two 
subgroups, nor did they correlate the successful outcomes to age.  Therefore, it seems that 
intervention implemented before 10 years of age produces promising results in obesity 
related outcomes, whereas intervention later than 10 years of age does not produce 
significant effects.  Further work is needed to determine whether age of intervention truly 
correlates with sustained improvements in obesity related outcomes.   
(iv) Length of intervention.  Several meta-analyses examined the impact of the 
length of intervention and its efficacy on obesity outcomes.  Interventions lasting 3 
months did not produce sustained reductions in BMI 9 months later (8), while those 
lasting more than 4 months were more promising (39, 47).  In a study examining longer-
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term endpoints, year-long interventions resulted in better outcomes 4 years later (50). 
Because most interventions are implemented for less than 6 months (8), inadequate 
duration of these programs could contribute to their limited efficacy. 
 
Summary of early intervention efforts in children 
The wide variety of programs designed to combat childhood obesity have not 
produced significant changes in the prevalence of adolescent nor adult obesity rates 
within the cohorts tested (2, 39).  The decreased efficacy of these programs suggests that 
current efforts implemented for obesity prevention are not working because they are 
either being implemented at the wrong age, in the wrong way, or for the wrong duration 
of time.  
 
Part III:  Intervention in Mouse Models of Obesity 
 Thus far, interventions in mouse models of obesity have been focused on 
intervention during adulthood.  Food restriction in adult rats has been shown to result in 
decreased EE driven by reductions in norepinephrine (NE) output, the primary 
neurotransmitter of the SNS (52-54).  Therefore, reduced EE drives weight regain in 
food-restricted adult rodents (52-55), similar to what is seen in adult humans.  Caloric 
restriction in young animals, however, primarily impacts linear growth, leading to 
reduced tissue deposition as opposed to altered EE (55).  Although reductions in growth 
may not be desirable, this provides evidence that intervention of increased body weight 
elicits differential age-dependent responses.  
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Existing mouse models of obesity 
 Several groups have developed rodent models of early-onset obesity to assess the 
influence of age or means of lifestyle intervention (via both caloric restriction and/or 
exercise) on obesity-related outcomes.   
 
1.  Litter size manipulation.  Overnutrition during the suckling period in rats, achieved by 
reducing the size of the litter, programs lasting increases in food intake and body weight 
(56).  Caloric restriction from 3-12 weeks of age in rats reared in a small litter size 
produced long lasting improvements in adult body weight (56).  However, this effect was 
lost when caloric restriction was implemented from only 3-6 weeks or 9-12 weeks of age 
(56).  Moreover, caloric restriction from 9-12 weeks of age resulted in rebound 
hyperphagia in response to resumption of ad libitum feeding, leading to increased weight 
gain (56).  This study provides evidence that there is a developmental window in the 
postnatal period where prolonged caloric restriction can produce beneficial outcomes.  
However, the major limitation to this approach is that the effect size is often modest, and 
in mice, differences in body weight tend to diminish over time. 
 
2.  Diet-induced obesity (DIO)-susceptible rats.  Barry Levin’s lab generated strains of 
rats that are preferentially sensitive or resistant to weight gain on a high fat diet (HFD).  
In response to HFD feeding, some Sprague-Dawley rats gained an abundance of weight 
(DIO-sensitive), while others in the same cohort did not (DIO-resistant, DR) (57).  By 
intercrossing DIO-sensitive and DR rats, they produced strains that reliably exhibited a 
pre-programmed response to HFD.  After many generations of intercrosses, DIO-
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sensitive rats exhibited normal body weights on chow, but would rapidly gain weight 
when fed a HFD (58, 59).  The weight gain exhibited by the DIO-susceptible rats was a 
result of increased caloric intake compared to the DR rats (58).   
The effects of early intervention from weaning (at 3 weeks of age) involving 
caloric restriction vs. exercise were compared.  The impact of restricting the caloric 
intake of HFD-fed DIO-susceptible rats by 15% from 3-9 weeks of age did not have any 
lasting impact on weight gain when rats were allowed to resume ad libitum feeding (60).    
Conversely, 3 weeks of post-weaning exercise resulted in reduced body weight and 
adiposity of DIO-susceptible rats even 10 weeks after the cessation of exercise, largely 
due to the lack of caloric compensation that usually accompanies exercise (61).  Early 
exercise intervention was also reported to increase leptin sensitivity in the hypothalamus, 
while caloric restriction did not (61).  While this model is useful in studying prevention 
of adult obesity, it is not a model for intervention methods of early-onset obesity as mice 
become obese later.  Additionally, continuous HFD feeding come with developmental 
consequences, such as permanent changes in the circuits regulating the neuronal reward 
pathway (62). 
 
3.  Genetic models manipulating leptin signaling.  Genetics manipulations have also 
produced early-onset obesity in rodent models.  The best-studied examples of genetically-
induced obesity involve deficits in leptin signaling. Leptin, a hormone found in 
proportional levels to adipose tissue (63) (as reviewed in (64)), is secreted by adipose 
tissue and regulates fat deposition and energy homeostasis (63-65). 
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(i) Global leptin/leptin receptor deficient models.  Leptin is known to regulate 
energy homeostasis through its effects on metabolism and appetite, and models of 
functional leptin receptor deficiencies (db/db mice/Zucker (fa/fa) rats) and leptin protein 
deficiencies (ob/ob mice) are hyperphagic and hypometabolic, resulting in increased fat 
deposition (66-68).  Paired-feeding of db/db mice to the intake of controls has been 
shown to lead to decreased body weight compared to never-restricted db/db, yet their 
body weight remained elevated compared to lean controls (69).  Similarly, early caloric 
restriction in Zucker (fa/fa) rats reduced body weight, but adiposity levels remained 
comparable to obese Zucker rats that had never been restricted (70).  In addition, ob/ob 
mice preferentially maintained increased adiposity in the face of reduced body weight 
when subjected to caloric restriction (71-74).  Taken together, these findings suggest that 
models involving global leptin signaling deficiency are not suitable for studying early 
intervention.   
  (ii) Other models with targeted disruption of leptin-mediated pathways.  The 
action of leptin on energy homeostasis is regulated through signal transducer and 
activator of transcription 3 (Stat3) (75).  A mutation in the leptin receptor (Lepr) isoform 
b in which tyrosine 1138, a docking site necessary for Stat3 activation, is replaced with a 
serine residue (s/s mouse) leads to robust early-onset obesity caused by a dysregulation of 
metabolic control (75).  Paired-feeding of s/s mice from 3-8 weeks of age failed to correct 
the increased fat deposition in these mice, regardless of a decreased body weight (69).  
Pro-opiomelanocortin (POMC) processing produces signal through the 
melanocortin-4 receptor (MC4R) to modulate energy homeostasis.  While global 
deficiencies in both POMC and MC4R cause obesity, the onset of obesity is delayed (76-
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79).  In contrast to the MC4R knockout (KO) mice, mice lacking another melanocortin 
receptor (MC3R) are only mildly obese and the onset of obesity is further delayed (80).  
Malcolm Lowe’s group demonstrated that knocking out the POMC in the arcuate nucleus 
of the hypothalamus (ARH) (arcPomc-/-) caused hyperphagia and body weight gain, with 
noticeable obesity at 5 weeks of age (81).  In arcPomc-/- mice, rescue of Pomc expression 
with a tamoxifen (TAM)-inducible cre recombinase normalized food intake at any age, 
but the effect on body weight was less effective when induced after postnatal day (P)60, 
and even less effective when induced after P180 (81).  Paired-feeding before the 
induction of TAM resulted in a full rescue of body weight when POMC in the ARH was 
restored, regardless of age at which restoration occurred (81).  These data support a role 
for early intervention in the peri-weaning period in which body weight baselines are 
being established.   
(iii) CCK1-receptor knockout model.  There are other hormonal factors aside 
from leptin that regulate food intake and body weight.  For example, cholecystokinin-1 
(CCK1) is another satiety factor.  The Otsuka Long-Evans Tokushima Fatty (OLETF) rat 
lacks the CCK1-receptor resulting in hyperphagia starting at birth, leading to obesity (82-
86).  Interestingly, the CCK1-receptor KO mouse model does not exhibit hyperphagia 
and does not become obese (87) and thus is not a model used for obesity.  The difference 
between the mouse and rat model of CCK1-receptor deficiency could be attributed to the 
difference in CCK1-receptor distribution, specifically in the brain (88). 
Similar to the DIO-susceptible model, acute exercise in male OLETF rats from 
weaning until P45 resulted in long-lasting improvements in body weight and adiposity, 
even 45 days after their running wheel was locked (wheel-lock), without compensatory 
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increased food intake (86).  Moreover, exercise implemented at a later age and longer 
period of time (8 -14 weeks of age) also produced long lasting effects on fat mass in male 
OLETF rats (89).  Female OLETF rats did not respond to exercise in the same way, 
suggesting a sexual dimorphic role of exercise in attenuation of obesity in the OLETF 
model (86).  However, differing from the DIO rat model, acute early paired-feeding from 
P23-P45 resulted in long lasting reductions of fat mass in male OLETF rats (85).  Similar 
to what was seen in response to exercise, there was a sexual dimorphic response to early 
caloric restriction, as female OLETF rats did not have long-lasting improvements in fat 
mass in response to acute early food restriction (84).  Interestingly, food intake was still 
permanently altered in these female mice, suggesting CCK1-receptor involvement in 
body weight might be a result of other mechanisms besides food intake in females (84).  
Caloric restriction in the male OLETF rat resulted in normalized NPY and POMC in the 
arcuate nucleus (ARC), which increases leptin sensitivity (90).  These changes might 
persist once early caloric restriction ends, contributing to the long-term reductions in food 
intake once paired-feeding ends (84, 85).  Consistent with observations in humans, this 
study highlights the need to evaluate the impacts of early intervention in both genders. 
 
Summary of intervention in rodent models of early-onset obesity (Table 1.1) 
 Of the limited number of early-onset obesity rodent models, few of these models 
are suitable for early intervention studies.  The DIO mouse and rat (58, 91, 92), POMC 
KO (77, 79), and MC4R KO (76, 78) models do not become obese until after 5 weeks of 
age, too late to study early intervention.  Weight-reduced leptin deficient models do not 
decrease adiposity in the same way as other models (69-74).  Additionally, some models 
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display a sexual dimorphic response to caloric restriction, such is the case in the OLETF 
rat model (84, 85).  Similar to the OLETF male rats, early intervention in rats reared in a 
small litter size resulted in persistent reductions in body weight gain (56).  Taken 
together, further work is needed to determine the best model and method for early 
intervention studies.  
Early exercise can also influence future body weight gain by influencing energy 
expenditure, while simultaneously affecting leptin sensitivity.  Subsequently, early 
exercise has been shown to lead to changes in metabolic rate without compensatory 
increases in food intake in both the OLETF and DIO-susceptible rats.  Although 
Schroeder et al. (2010) documented changes in food intake of the OLETF rat in response 
to caloric restriction and/or exercise, the significance in food intake is only present at 
certain time points and not across the recovery period (85, 86).  Therefore, the changes 
seen in body weight post-intervention might be caused by changes in EE as opposed to 
reprogramming of food intake.  Long-lasting changes in thermogenesis leading to 
increased EE have not yet been looked at as mechanisms of prolonged weight loss 
interventions, yet there has been supporting evidence that early weight gain results in 
long lasting reductions in thermogenesis resulting from abnormalities in brown adipose 
tissue (BAT) (93).  Further work is needed in order to elucidate how body weight 
baselines become established, and whether it can be regulated by changes in thermogenic 
baselines.  
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Rodent model Onset of obesity 
 
Early caloric intervention 
of models of early-onset 
obesity 
DIO-Susceptible rat and DIO 
mouse 
Body weight increased >5 
weeks on chow; % Body 
fat; NS on chow (58, 91,92)  
 

















Obese by 3 weeks (66) 
Predisposition to keep 
increased % body fat in the 
face of weight loss (71-74) 
 
 
db/db mouse, Zucker fa/fa rat 
 
 
Obese by 3 weeks (67, 68) 
Zucker; Increase body fat (70) 
 
Db/db; Increased body weight 
compared to controls when 
pair-fed (69). 
s/s mouse Obese by 3 weeks 
(75) 
 
Increased fat deposition in the 







Obese by 3 weeks (85, 86) 
Reduced fat mass 
Absence of compensatory 
hyperphagia (85) 
 
Small Litter Size manipulation Obese by 3 weeks (56, 93) Long-lasting improvements in 
body weight (56) 
 
 
Table 1.1:  Mouse models of early-onset obesity.  DIO-susceptible, Mc4r KO, Pomc 
KO, and OLETF mouse models become obese too late to be considered for models of 
childhood obesity (gray shaded boxes).  Ob/ob, db/db, s/s mice, and Zucker fa/fa rats, do 
not respond normally to caloric restriction (red font).  The OLETF rat and the small litter 
size manipulation are two models that succeed in long-term reductions of adiposity in 
response to caloric restriction (Light blue shaded boxes). BW (Body weight). DIO (Diet-
induced obese).  Pomc; Pro-opiomelanocortin.  Mc3r/Mc4r; Melanocortin-3/4 receptor. 
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Part IV:  Thermogenesis: Brown Adipose Tissue Function and Regulation 
Thermogenesis 
Adaptive thermogenesis is the protective mechanism by which an organism 
regulates body temperature and energy balance in response to external temperature (i.e. 
cold) and diet (94-97).  The two main types of thermogenic mechanisms are shivering, 
controlled by the skeletal muscle, and non-shivering (adaptive) thermogenesis, controlled 
primarily through the BAT (98).  Additionally, diet-induced thermogenesis (via diet 
action onto BAT) and behavioral thermogenesis (huddling of young animals) contribute 
to thermogenesis of a rodent. 
BAT is the main thermogenic organ in the rodent (93), and it is characterized by 
being mitochondria-rich and multilocular in structure (containing an abundance of small 
lipid droplets) (93, 99, 100), making it distinct from white adipose tissue (WAT), which 
is unilocular with few mitochondria (100).  BAT is developmentally distinct from WAT 
and is derived from the myogenic precursor myogenic factor 5 (Myf5), and the 
upregulation of PR domain containing 16 (Prdm16) expression differentiates Myf5 
containing pre-adipocytes to BAT instead of muscle (100-102).  The mitochondrion of 
the BAT is the key site of its thermogenic action (94, 103) via uncoupling protein 1 
(UCP1) located on the cristae (99, 103-106).  UCP1 uncouples the proton gradient from 
adenosine triphosphate (ATP) production to release energy in the form of heat (94, 103), 
and is essential for cold-induced non-shivering thermogenesis (107, 108).  Genetic 
models of obesity have impaired mitochondrial structure and function, resulting in 
impaired thermogenesis (109), thus making them cold intolerant (109).  Small litter size, 
known to drive increased body weight gain in rodents, also leads to reductions in 
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thermogenesis as seen by reduced UCP1 in response to cold (93).  Therefore, obesity is 
partially mediated by an inability to properly regulate adaptive thermogenesis. 
 
Thermoregulation of brown adipose  (Figure 1.2) 
The SNS activates BAT through secretion of NE, which acts through the β3-
adrenergic receptor (β3-AR) to upregulate UCP1 via a cyclic adenosine 
monophosphate/protein kinase A (cAMP-PKA)-dependent mechanism (97, 110).  
Knocking out β-adrenergic receptors leads to a reduced thermogenic effect of NE in 
rodents (101).  In UCP1 KO mice, NE is unable to elicit a thermogenic response, 
suggesting the effect of NE on non-shivering thermogenesis is through a UCP1-
dependent pathway (97, 108).  Moreover, inactivation of β-hydroxylase to diminish 
endogenous epinephrine and NE results in mice that are cold intolerant and unable to 
mount a UCP1 response during cold exposure (111), providing evidence that cold-
induced thermogenesis is dependent on NE-induced UCP1 activation (111).  Cold and 
diet-induced thermogenesis activate BAT thermogenesis via similar mechanisms through 
the SNS in the rodent (112). 
 Thyroid hormone is necessary for BAT thermogenic function, and acts 
synergistically with the SNS to upregulate Ucp1 gene expression (113, 114).  
Hypothyroid rats are cold intolerant, which can be rescued upon thyroid hormone 
treatment (115).  Additionally, hypothyroid rats are unable to mount a thermogenic 
response to NE (113, 114) highlighting the permissive role of thyroid hormone on SNS-
induced thermogenesis.  Thyroxine (T4) is transported into the brown adipocyte and is 
converted into the active thyroid hormone, 3,3’,5-triiodothyronine (T3), by deiodinase 2 
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(DIO2) (113).  NE stimulates the cAMP-PKA pathway to lead to increased Dio2 
upregulation and the conversion of T4 to T3 (116).  T3, either produced by DIO2 or 
transported into BAT from serum, can influence mitochondrial Ucp1 expression, as well 
as the production of cAMP (114).  It has been shown that brown adipocytes isolated from 
hypothyroid rats had reduced capacity to generate NE-mediated cAMP compared to 
euthyroid rats (114).  This further supports the idea that that there is an interplay between 
thyroid hormones and the SNS in order to produce maximal BAT activation.  
Additionally, mice lacking DIO2 (D2KO) become obese at thermoneutrality but not at 
room temperature (113, 117).  The lack of obesity at room temperature in D2KO mice is 
a result of compensatory upregulation of SNS tone onto BAT, which is then blunted at 
thermoneutral conditions (113).    
 
BAT development 
 BAT is highly vascularized and innervated (93, 94, 97, 99), and its thermogenic 
output is regulated by the SNS (94, 97, 101, 118).  Formation of the BAT depot does not 
rely on SNS activity, as BAT is fully formed in neonates before SNS activity is detected 
(119-121).  At birth, the mitochondria of the BAT have dense lipid filled inclusions that 
disappear within 1-2 days (122).  There is a rise in postnatal Ucp1 expression in BAT 
within the first 24 hours of life (123), which coincides with the disappearance of lipid 
filled inclusions of the mitochondria.  Postnatal induction of Ucp1 is abolished when 
neonates are reared in thermoneutral conditions, indicating that the early Ucp1 
upregulation in neonates is in response to the cold stress of the environment (123).  In 
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sheep, it has been found that there is a surge in NE around the time of birth, which could 
influence BAT activation further (124). 
 
 
BAT is innervated by the SNS at two different locations, the parenchyma and the 
blood vessels (120, 125).  Immunosympathectomy (preventing sympathetic outgrowth) of 
	  
Figure 1.2.  Thermogenic regulation of brown adipose tissue.  HFD and cold 
stimulate the SNS to release NE.  NE acts on the β-AR receptors to activate 
mitochondrial UCP1 in a cAMP-PKA-dependent mechanism.  Additionally, T4 can be 
transported into BAT.  cAMP can upregulate Dio2 to convert T4 into its active form, 
T3, to influence UCP1.  Upregulation of Ucp1 releases energy in the form of heat.  T3 
can also contribute to the generation of cAMP. Abbreviations: HFD; high fat diet.  
NE; norepinephrine. β3-AR; β3-adrenergic receptor. cAMP; cyclic adenosine 
monophosphate.  PKA; protein kinase A. T4; Thyroxine. T3; 3,3’,5-Triiodothyronine. 
DIO2; deiodinase 2. UCP1; Uncoupling protein 1.  Adapted from de	   Jesus	   LA,	  
Carvalho	   SD,	   Ribeiro	  MO,	   Schneider	  M,	  Kim	   SW,	  Harney	   JW,	   et	   al. J Clin Invest. 
(2001). Reference (211). 
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rodent BAT from P0-5 does not eliminate parenchymal innervation of BAT, indicating 
that BAT SNS innervation into the parenchyma is developed prior to birth (120).  
Outgrowth of projections from the sympathetic ganglia onto the BAT depot can be 
detected at P2 (120).  Sympathetic projections penetrate into BAT by traveling along 
blood vessels, which is largely completed by P10 (120). Sympathetic axons branch and 
expand to occupy the parenchyma, reaching adult levels by P21 (weaning) (120).   
(i) Growth factors and neuroendocrine control of BAT neonatal development.  
The BAT depot forms during gestation, but is not active until birth.  Following 
parturition, BAT activity is “unmasked” through the actions of secreted factors, and not 
neuronal signals.  Prolactin, which is secreted by the anterior pituitary to stimulate 
mammary gland development and lactation, is critical to the differentiation and growth of 
BAT during gestation and the early postnatal period (126, 127).  Prolactin receptors 
(PRLR) are highly expressed in neonatal BAT, and PRLR KO mice have severely 
decreased BAT mass at birth, reduced Ucp1 mRNA and protein levels, and 
morphological abnormalities in BAT mitochondria, resulting in severe cold intolerance 
(127).  Prolactin works in concert with insulin-like growth factor 2 (IGF-2) to control 
BAT differentiation at birth (127).  IGF-2 is not necessary for further growth of the 
depot, as IGF-2 declines within several weeks of birth (127). 
BAT DIO2 is important during the late gestational/early postnatal period (128).  
Hypothyroid dams (and subsequently developing fetuses) exhibit decreased BAT Ucp1 
gene expression in utero, and the sharp increase of Ucp1 within 24 hours post-birth is 
blunted (129).  Moreover, DIO2 is important during development, and when knocked out 
during differentiation, it leads to defective maturation of the brown adipocytes (130).  
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This suggests that a normal thyroid environment is needed for proper thermogenic 
capacity of BAT (129).  Therefore, thyroid hormones play a crucial role for the 
functionality of the BAT during gestation and the early postnatal period, and it has the 
ability to increase Ucp1 in a thermoneutral condition (such as in utero) (131).  
Additionally, T3 has been hypothesized to play a role in the expansion of the BAT depot 
during fetal development (121). 
BAT development is also under the trophic control of growth factors.  Insulin-like 
growth factor 1 (IGF-1) is important for organ differentiation of fetal BAT (119, 132), 
and its receptor (IGF-1R) increases during BAT differentiation (121).  IGF-1 in 
conjunction with T3 could aid in the expansion of BAT in the absence of NE during fetal 
development (121).  Nerve growth factor (NGF) is important for sympathetic innervation 
(132) and BAT proliferation (133) and is under inhibitory control of NE (132).  NGF is 
inversely correlated to SNS tone onto BAT (119), and thus decreased SNS tone results in 
increased BAT NGF (132).  Consistent with these findings, obese mice have increased 
BAT NGF levels compared to lean controls (132), most likely due to a compensatory 
mechanism for the decreased SNS tone in obese mice.  In contrast, cold, which is known 
to increase sympathetic tone, lowers BAT NGF levels (119).  Therefore, NGF might be a 
compensatory mechanism of sympathetic innervation when SNS tone is low (132). 
Fibroblast growth factors (FGF) are also important in BAT growth and 
development.  FGF-16 stimulates BAT proliferation during gestation (100), while FGF-
15 plays a role in BAT expansion and thermogenic capacity (100).  Similarly, FGF-21 
becomes present within 48 hours after birth and influences increases in BAT capacity 
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(134).  FGF-2 is also important in the recruitment and hypertrophy of BAT in response to 
cold (135). 
(ii) Leptin and BAT development.  Leptin does not seem to be required for BAT 
development during gestation (136), however it has a crucial differential role in BAT 
proliferation and thermogenesis during the early postnatal period (137, 138).  In the 
postnatal period, serum leptin levels, primarily secreted from BAT (139) are elevated 
(139, 140), with a peak in levels at P10 (137, 140).  Interestingly, BAT leptin levels are 
inversely correlated with SNS activity onto BAT, and neonates reared in thermoneutral 
conditions exhibit increased circulating leptin (139).  Moreover, leptin administration in 
the early postnatal period reduces BAT UCP1 in sheep (141), and thyroid hormones in 
rats (142).  The SNS tone onto BAT is influenced by leptin (94, 136, 143-147), and early 
leptin-treatment (P4-P14) to ob/ob mice results in enhanced cold tolerance (138).  
Increased activity in thermogenic circuits during the first few postnatal weeks can 
permanently program improvements in thermoregulation in ob/ob mice (138).   
 
Central regulation of adult BAT  (Figure 1.3) 
BAT is regulated by various regions within the hypothalamus, including the 
paraventricular nucleus (PVH), preoptic area (POA), arcuate nucleus (ARH), ventral 
medial nucleus (VMH), dorsal medial hypothalamus (DMH), and lateral hypothalamus 
(LH), as well as extrahypothalamic regions, such as the nucleus tractus solitarii (NTS) 
(148) or ventral tegmental area (VTA) (149).  The LH synthesizes the neuropeptide 
orexin, and orexinergic neurons can project to the orexin receptors in the rostral raphe 
pallidus (rRPA) to amplify sympathetic activity onto BAT (150).  Conversely, the PVN 
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contains inhibitory neuronal influence over BAT activation through the rRPA (148, 151), 
and provides a control mechanism that is under the influence of nutritional and metabolic 
regulation.  PVH control of BAT thermogenesis is mediated in part by the ARH, and both 
NPY and POMC have influence on the thermogenic control of BAT via the PVH (152, 
153).  Moreover, central nervous system (CNS) injections of NPY increase adiposity, 
even when mice are being pair-fed, suggesting that NPY influences EE (153) 
independent of food intake.  Infusion of MTII (an MC4R agonist) into the PVH has been 
shown to increase BAT thermogenesis (152, 154, 155).  Therefore, the NPY and POMC 
neuronal projections from the ARH to the PVH influence BAT thermogenesis (152, 153).  
Recent studies have also implicated agouti-related peptide (AgRP) in the regulation of 
BAT through projections to the anterior bed nucleus of the stria terminalis (156).  
Retrograde labeling of BAT using pseudo rabies virus has implicated the POA of 
the hypothalamus as an important regulator of BAT thermoregulation (97, 157).  
Thermosensory receptors on the skin send signals through the spinal dorsal horn to 
activate the parabrachial nucleus projections to the POA (148).  The POA exerts inputs 
onto the DMH, which is the primary brain region influencing BAT thermogenesis in 
response to temperature (152, 158).  The thermoregulatory control of the DMH onto BAT 
is mediated through the rRPA (148, 152, 159).  Subsequently, blocking the DMH 
prevents SNS-mediated BAT activation (160).  Additionally, the rRPA region is 
necessary in the thermosensory control of BAT, as de-activation of the rRPA results in 
reduced body temperature (148).  The VMH also receives inputs from the POA that 
regulates BAT thermogenesis, and cooling and warming the cold-sensing neurons and the 
warm-sensing neurons respectively activates and deactivates BAT, through inhibitory 
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outputs onto the VMH (97, 161).  Lesions of the VMH lead to atrophy of BAT (97), and 
suppression of the ability for acute cold (97, 162) or cooling of the POA to stimulate 






Figure 1.3. Hypothalamic influences of sympathetic regulation of BAT.  
Temperature influences the temperature sensing neurons in the POA to stimulate 
hypothalamic nuclei to influence BAT thermogenesis mediated by the rRPA.  The 
ARH mediates PVN inhibitory control of the rRPA through action of NPY/AgRP and 
POMC neurons.  The POA projects to the DMH and VMH to act on the rRPA to 
influence BAT thermogenesis.  The rRPA signals to BAT through the sympathetic 
ganglion. Abbreviations:  POA; preoptic area.  NPY/AGRP: neuropeptide Y/agouti-
related peptide.  ARH; arcuate nucleus of the hypothalamus.  VMH; ventral medial 
nucleus of hypothalamus.  DMH; dorsal medial hypothalamus.  PVH; periventricular 
nucleus of hypothalamus.  LH; lateral hypothalamus.  rRPA; rostral raphe pallidus.  
BAT; brown adipose tissue.  Figure adapted from Zhang W , Bi S. Front Endocrinol 
(Lausanne). [Internet] (2015). Reference (212).   
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(i) Leptin effects on SNS control of BAT.  In adulthood, leptin infusion can elicit 
a thermogenic response and intracerebroventricular (ICV) injections of leptin into the 
VMH results in increased SNS tone onto BAT (163).  It is thought that leptin-mediated 
SNS tone is mediated through the melanocortin system in adulthood, as some studies 
have indicated that MC4R KO mice are unable to elicit a thermogenic response upon 
peripheral leptin injection (145).  Additionally, while leptin ICV injection increases BAT 
UCP1 in control mice, co-administration with SHU9119, an α-melanocortin stimulating 
hormone (α-MSH) inhibitor, has been shown to inhibit leptin-induced thermogenesis 
(144).  There have been contradictory reports as to whether SHU9119 co-administration 
inhibits leptin’s effect on BAT UCP1 (146), which could be due to different experimental 
conditions.  Additionally, although MC4R KO mice are cold intolerant, further 
supporting the role of MC4R in thermoregulation, prolonged cold exposure results in 
increased cold tolerance (152).  Therefore, there are compensatory mechanisms by which 
melanocortin-dependent thermogenesis is regulated (152). 
 
Peripheral regulation of BAT activation (Figure 1.4) 
 (i) Liver secreted factors.  BAT can also be activated through stimuli in the 
periphery, especially the liver (164).  FGF21, primarily secreted by the liver, regulates 
energy and glucose homeostasis, and exogenous FGF21 results in weight loss effects 
(165-167).  Interestingly, models of obesity exhibit relatively high levels of circulating 
FGF21, supporting the hypothesis that obesity might be a state of FGF21 resistance (166, 
167).  BAT can also secrete its own FGF21 to upregulate BAT thermogenesis (168). 
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 Bile acids are another factor released from the liver that can drive BAT 
thermogenesis (164).  Bile acids activate BAT via the TGR5 receptor in a mitogen-
activated protein kinase (MAPK) dependent pathway, through its action on DIO2 
(subsequently converting T4 to T3) (169).  Synthesis of T3 within the BAT results in 
BAT thermogenesis (164).  Rodents fed a HFD supplemented with bile acids leads to 
significantly less weight gain, with increased oxygen consumption, compared to HFD 
consumption alone (169). 
	  
Figure 1.4.  Peripheral activators of BAT.  NE from the SNS acts through the β3-
AR.  BAT produces BMP8b that acts on its BAT receptors to increase thermogenesis.  
The liver secretes bile acids and FGF21 that interacts with TGR5 and FGFR/KLB 
respectively. The heart produces natriuretic peptides that also influence thermogenesis.  
Abbreviations: SNS; sympathetic nervous system.  NE; norepinephrine.  β3-AR; β3 
adrenergic receptor. BMP; bone morphogenic protein. FGFR; fibroblast growth factor 
receptor.  KLB; β-klotho.  FGF21; fibroblast growth factor.  NPR; natriuretic peptide 
receptor. UCP1; uncoupling protein 1.  Figure adapted from Villarroya, F, Vidal-Puig, 
A.  Cell Metabolism. (2013).  Reference (164). 
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(ii). Heart-secreted BAT activating factors.  Two other organs implicated in BAT 
regulation are the heart and the BAT itself.  The heart produces hormones called 
natriuretic peptides (NP) that can act through the BAT natriuretic peptide receptor (NPR) 
to stimulate BAT thermogenesis (164).  Rodents lacking the clearance receptor for NPs 
have enhanced activation of BAT in conjunction with reduced body fat deposition (164).   
 
(iii) BAT autocrine regulation of thermogenesis.  The BAT makes bone 
morphogenic protein 8b (BMP8b), a growth factor, that can act on itself through its 
receptor (BMP8bR) to enhance thermogenesis (170).  BMP8b is correlated with 
nutritional status, and KO models of BMP8b result in decreased EE, are temperature 
sensitive, and exhibit increased weight gain in the presence of HFD (170).  BMP8b can 
also have CNS-dependent effects on sympathetic control of BAT thermogenesis (170). 
Taken together, there are a number of organs that can contribute to BAT 
activation via hormones and growth factors that they secrete.  Some of these secreted 
factors have been used as therapeutic strategies to enhance BAT activation, but more 
work is needed in order to elucidate which mechanism might have the most beneficial 
impact. 
 
Part V:  Modulation of BAT Capacity and Activity (Table 1.2) 
The SNS innervates BAT via the stellate ganglion; these projections are critical 
for cold-induced thermogenesis (97, 118, 171, 172).  Exogenous NE administration can 
override a ganglionic blockade (118), by acting directly on β3-ARs on BAT.  The rate of 
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NE turnover has been used as a surrogate for BAT activity, while response to exogenous 
NE has been used as a surrogate for BAT capacity (how well the BAT can respond to 
stimulation) (97).  Both capacity and activation are required to maximize BAT function 
(97) (Figure 1.5).  Models of obesity have lower thermogenic capacity, demonstrated by 
distorted BAT mitochondria (Figure 1.5) and inability to respond to exogenous NE (109, 
173, 174), as well as being cold intolerant (173). Additionally, obese models have 
decreased SNS tone onto BAT, as defined by reduced NE turnover (175, 176).  
Decreased BAT capacity and activity precede obesity in these models (176, 177), 
consistent with the idea that deficits in BAT thermogenic responses contribute to the 
subsequent development of obesity (178).  Moreover, it has been shown that treatment 
with a β3-AR agonist between 8-16 days of age restores thermogenic capacity of BAT in 
obese rodents, further indicating that decreased BAT capacity was impaired due to 
impairments in SNS activity (179). 
	  
Figure 1.5.  Brown adipose tissue capacity and activity.  A) Mitochondria of lean 
rodents with tightly packed cristae. B) Mitochondria of obese rodent with disrupted 
cristae. C) Relationship between capacity of mitochondria and its activity to acute 
stimuli to mount a thermogenic response.  Figure adapted from Cannon B, 
Nedergaard J. Physiol Rev. (2004).  Reference (97). 
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Thyroid hormone 
T4 can influence BAT capacity by restoring mitochondrial structure (174), yet can not 
directly activate BAT (97, 174).  There is an interaction between T4 and NE in BAT 
activation and in response to stimuli, such as cold (114).  Although genetically obese 
mice do not exhibit increased thermogenesis upon treatment with T4, treatment with T4 
elicits an improved response to exogenous NE and cold (174), supporting a permissive 
role for T4 in improving BAT capacity to respond to endogenous/exogenous stimuli (97, 
174). 
 
Caloric restriction and cold acclimation 
There are several other factors that influence BAT capacity.  Although caloric 
restriction reduces metabolic rate through mechanisms stated earlier, it has beneficial 
impacts on BAT capacity.  Caloric restriction results in enhanced response to exogenous 
NE in obese mice (180) due to increased binding capacity of the mitochondria (181).  
Similarly, cold acclimation can induce a thermogenic response (173).  Although obese 
rodents do not respond favorably to acute 4°C stimulus and are cold intolerant, gradual 
acclimation to cold is able to restore mitochondrial structure and capacity to respond to 
exogenous NE (173, 182, 183), as well as to increase NE turnover in BAT of obese mice 
(184).  Additionally, cold is reported to upregulate Dio2 in lean rodents (185).  This 
upregulation is blunted in ob/ob mice, consistent with the idea that cold intolerance in 
these mice is, in part, due to impaired Dio2 (185). 
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Rearing temperature 
Rearing temperature can have long lasting implications on metabolic status of an 
animal.  Rearing rats in cold temperatures increases SNS innervation in BAT (171, 186), 
and increases NE content (171) compared to rats reared in warm temperatures, suggesting 
that early exposure to BAT-activating environments have neuroregulatory influences on 
BAT.  Pups reared at cold temperatures also have long-lasting improvements in cold 
tolerance (186).  Conversely, warm temperatures decrease NE turnover and content 
leading to reduced BAT activity (171, 184), as well as the ability to respond to exogenous 
NE (182).  Interestingly, although rodents reared at 18°C have increased SNS innervation 
along with increased BAT NE turnover and UCP1 levels, they have increased 
predisposition to gain weight on a HFD compared to mice raised at 30°C (186).  
Increased body weight gain could be due to hyper-innervation of the BAT, reducing 
sensitivity to thermogenic stimuli (186). 
 
High fat diet 
Interestingly, a HFD can stimulate a thermogenic response of BAT known as diet-
induced thermogenesis (96, 97, 187, 188).  Diet induced thermogenesis is mediated in a 
UCP1-dependent manner (187).  HFD feeding increases depots of BAT and elicits 
structural changes of BAT similar to that of adaptation to cold (96, 177).  Additionally, 
HFD increases UCP1 protein levels (187) leading to increased EE (96).  HFD also 
increases NE turnover, similar to that seen in cold exposure (101).  Similarly, rats fed a 
HFD exhibited an even more robust increase in rectal and interscapular temperature when 
injected with NE (96), further supporting the fact that HFD not only activates the BAT, 
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but improves its capacity to respond to stimuli.  This effect of HFD is not lost in 
genetically obese mice, as HFD feeding in ob/ob mice results in increased SNS activity in 
BAT, capacity of BAT to respond to NE, and improvements in cold tolerance (188).  The 
effect of HFD is a compensatory mechanism to combat increased caloric consumption. 
 
Intervention BAT capacity BAT activity BAT activity + NE 





T4 Increased (174) Unchanged (97, 
174) 
Increased (174) 
Cold Increased (184) Unchanged 
(173) 
Increased (173) 
HFD Increased (96) Increased (96, 
97, 187, 188) 
Increased (96) 
Table 1.2.  Intervention strategy on BAT capacity and activity in obese rodents with 
and without norepinephrine.  Caloric restriction improves BAT capacity to respond to 
exogenous NE.  T4 has a similar effect.  Obese rodents are cold-intolerant, but cold 
increases BAT capacity to respond to exogenous NE.  HFD increases BAT capacity and 
activation, further increasing activity in response to NE.  
Abbreviations: NE: norepinephrine.  HFD: high fat diet. T4: Thyroxine. 
 
Part VI:  BAT Relevance in Humans 
 
Brown adipose tissue presence humans 
The classical BAT depot (interscapular BAT, iBAT) relevant to rodents is also 
extremely active in humans during infancy (189).  IBAT activity declines with age (189), 
contributing to the old dogma that human BAT was only relevant during infancy, and not 
in adulthood (as discussed in (190, 191)).  This hypothesis has been debunked, as BAT 
was determined to be the cause of many false positive 18F-flurodeoxyglucose (FDG) 
positron-emission tomography (PET) uptake studies routinely performed in cancer 
patients (191, 192).  Adipose tissue is known to be the site of glucose uptake via its 
glucose transporter (GLUT4), and thus metabolically active tissue will result in increased 
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glucose uptake, and thus an increased FDG uptake (191).  Further analysis of false 
positive readings indicated that glucose uptake is further exacerbated by cold (190, 193-
195), indicative of BAT activation.  Differing from what is found in infants (and rodents), 
the main depot in BAT in the adult is found in the supraclavicular region (196).  
Histological (190, 193) and molecular (190) analysis of the adipose tissue in the 
supraclavicular region confirmed BAT identity, with increased innervation by the SNS 
and increased expression of UCP1 (197).   
Metabolically active adipose tissue comes in two types, the classical BAT (cBAT) 
and beige/”brite” adipose tissue.  Beige adipose tissue is Myf5 negative, and is generated 
from mature WAT that can become metabolically active and expresses UCP1 and other 
thermogenic markers (as reviewed in (198)).  Although it is widely agreed upon that 
infant BAT is of cBAT origin (199), many of the BAT depots found in adults are thought 
to be of beige fat origin as opposed to the cBAT seen in rodents (200).   
 
Brown adipose tissue in response to cold in humans 
Although BAT activity is not present in all individuals at thermoneutral 
conditions, BAT can be stimulated upon cold exposure (190, 193-195, 201), leading to 
increased EE (193, 202).  Because human BAT is responsive to cold, non-shivering 
thermogenesis is hypothesized to be relevant to humans (193).  Moreover, cold exposure 
coincides with reductions in temperature of non-BAT regions, along with increased 
temperature of supraclavicular BAT, further indicating BAT activation in response to 
cold stimulation (203).  Similar to what is found in rodents, human BAT can also be 
activated by adrenergic stimulation (204), yet this is has been shown to only be effective 
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in lean individuals (204).  Additionally, the adrenergic stimulatory findings contradict 
other studies that found cold, but not ephedrine (an adrenergic stimulus), stimulates 
increased BAT activity (204, 205).  Variations in BMI/weight, age, gender, and 
environmental temperature can influence the discrepancies found in these studies.   
 
Age and BMI correlation to brown adipose tissue activity 
There are many factors that influence BAT activation in humans.  BAT activity is 
correlated with age; younger individuals have increased cold-induced BAT activation 
compared to older individuals (193, 195, 202).  Additionally, BAT activity has been 
shown to be inversely correlated to BMI (201, 206), and the number of BAT-positive 
islands found within white fat is correlated with leanness (197), thus reduced BAT 
activity could drive obesity.  Conversely, other groups have demonstrated obese 
individuals can elicit BAT activity during cold exposure (195, 202), similar to the cold-
induced response seen in lean subjects (195).  These findings might suggest that beige 
adipose tissue or BAT can be recruited upon cold exposure when performed in young 
healthy individuals, independent of BMI (195).  Interestingly, weight loss induced by 
laparoscopic gastric banding surgery results in increased BAT responsiveness to cold 
(207), similar to the BAT capacity improvements of caloric restriction in rodent models 
(180).  Discrepancies in amounts of BAT activation detected in lean versus obese 
individuals in response to cold could be due to differences of temperatures within studies 
(uniform vs. personalized cooling methods) as well as the age of the individuals (197, 
202).  Increased BAT activity has been associated with decreased cardiovascular disease 
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independent of age and BMI (208), raising the possibility that human BAT might 
contribute to cardiometabolic status of an individual and not just body weight. 
 
Brown adipose tissue activity during the transition from childhood to adulthood 
There is a peak in BAT activation during adolescence (Figure 1.6), which is 
dampened in obese children (209).  BAT activity can be correlated with EE, and therefore 
the peak of activity during adolescents is a time of elevated EE.  This might be a potential 
mechanism by which basal metabolic rate is established during the pubertal time period.  
Obesity might be associated with reduced BAT capacity and activation at room 
temperature, as shown by the lack of response to ephedrine (204), but BAT capacity 
might be improved upon cold stimulus (195).  While ephedrine use is not recommended 
to treat obesity due to its adverse side effects (i.e. increased blood pressure) (204), this 
study in combination with studies including cold stimuli suggest BAT might still be a 
therapeutic organ to combat obesity.  
	  
Figure 1.6. Peak of BAT activity in adolescents.  BAT activity normalized to liver 
activity.  Blue bar represents male, pink bar represents female.  Figure was generated 
using data from Drubach LA, Palmer EL, Conolly LP, Baker A, Zurakowski D, 
Cypess AM.  J Pediatr. (2011). Reference (209). 
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Part VII: Summary 
Although there have been some studies showing that early intervention can result 
in lasting effects on body weight, the mechanism behind this outcome remains unclear.  
By understanding the mechanistic drivers by which early intervention might reprogram 
adiposity baselines, we might be able to determine more efficacious strategies to combat 
childhood obesity in humans.  The first goal of this thesis was to determine whether early 
intervention in a mouse model of early-onset obesity would produce long lasting effects 
on adiposity.  We addressed this question using a mouse model of early-onset obesity 
generated by the lab, the Nkx2.1-Cre (LeprNkx2.1KO), which lacks the leptin receptor in 
most of the hypothalamus.  The resulting mice exhibit hyperphagia, reduced EE, and 
obesity (210).  The LeprNkx2.1KO mouse, which exhibits increased body fat at weaning, 
differs from the other models of leptin deficiency in that its adiposity stabilizes between 
8-12 weeks of age (210).  Adiposity stabilization suggests that there is a critical 
developmental window in which adiposity set points are being established.  We 
hypothesized that intervention in this time window is not accompanied by the decreased 
EE that typically accompanies caloric intervention in adults. 
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CHAPTER 2: Reducing Adiposity in a Critical Developmental 
Window has Lasting Benefits in Mice 
Part I: Manuscript   
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ABSTRACT  
While most adults can lose weight by dieting, a well-characterized compensatory 
decrease in energy expenditure promotes weight regain more than 90% of the time. Using 
mice with impaired hypothalamic leptin signaling as a model of early-onset hyperphagia 
and obesity, we explored whether this unfavorable response to weight loss could be 
circumvented by early intervention.  Early-onset obesity was associated with impairments 
in the structure and function of brown adipose tissue (BAT) mitochondria, which were 
ameliorated by weight loss at any age.  Whereas decreased sympathetic tone in weight-
reduced adults resulted in net reductions in BAT thermogenesis and energy expenditure 
that promoted rapid weight regain, this was not the case when dietary interventions were 
initiated at weaning.  Enhanced energy expenditure persisted even after mice were 
allowed to resume over-eating, leading to lasting reductions in adiposity.  These findings 
reveal a time window when dietary interventions can produce metabolic improvements 
that are stably maintained.  
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 INTRODUCTION   
Approximately 17% of U.S. children and adolescents are obese (1).  As childhood obesity 
increases the risk of developing diabetes and cardiovascular disease (2), there is an urgent 
need to combat this epidemic.  Many of the co-morbidities associated with obesity can be 
forestalled by maintaining even a modest degree of body weight loss (3, 4). 
Unfortunately, programs aimed at preventing childhood obesity involving “common 
sense” behavioral modifications to diet and/or physical activity have not produced 
significant improvements in body mass index (BMI) (5, 6).  The contribution of resting 
energy expenditure (REE) to the risk of obesity and/or efficacy of intervention strategies 
in children has largely been ignored.  This is a major oversight, since modest (4-7%) 
reductions in basal metabolic rate have been linked to increased risk of weight gain in 
non-dieting subjects (7) and are thought to promote regain in the weight-reduced state (8, 
9). 
 
There are two lines of evidence to suggest that there are discrete development periods 
when the “rules” of energy balance as defined in adults do not apply.  First, a model that 
accurately predicts REE in young children and adults is consistently ~7% too low when 
applied to teens (10).  Second, weight loss in young children is not necessarily followed 
by a compensatory decrease in free triiodothyronine (fT3), the active form of thyroid 
hormone that is often used as a surrogate measurement for basal metabolic rate (11).  
Moreover, the failure to exhibit a compensatory decrease in fT3 correlates with 
successful weight loss maintenance in young obese children (11).  These observations 
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raise the possibility that there is a window of opportunity for weight loss interventions in 
young children without the compensatory decrease in REE that promotes regain.  
 
A major obstacle to studying whether early interventions can produce sustained 
improvements in obesity-related outcomes in pre-clinical rodent models is the ability to 
generate obese animals before puberty is initiated at 4-5 weeks of age (12).  We 
developed a mouse model of genetically-induced early-onset hyperphagia and obesity 
with the goal of identifying drivers of childhood obesity that respond to early 
intervention.  Mice with genetically-induced hypothalamic leptin resistance (Nkx2.1-
Cre;Leprflox/flox mice, hereafter referred to as KOs) are hyperphagic and exhibit increased 
adiposity from weaning at 3 weeks of age (13).  We used this model to explore whether a 
reduction in adiposity before puberty is not accompanied by a compensatory decrease in 
energy expenditure, and if true, whether early improvements in obesity-related outcomes 
are long-lasting. 
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METHODS 
Mouse husbandry.  All mouse protocols were overseen and approved by the Columbia 
University Medical Center Institutional Animal Care and Use Committee.  Mice were 
maintained in a temperature (22+/- 1˚C) and light controlled (12 hours light: 12 hours 
dark) barrier facility.  Unless otherwise indicated, mice were singly housed from weaning 
and had ad libitum access to chow (13.2% energy from fat, 5053* PicoLab Rodent Diet 
20) and autoclaved drinking water. 
Generation of LeprHYPKO mice.  To disrupt LepRb signaling in the hypothalamus, mice 
homozygous for the floxed allele of Lepr (FVB.BKS(D)-Leprdb provided by S. Chua, 
Albert Einstein College of Medicine) (14) were crossed with the Nkx2.1-Cre driver line 
(C57BL/6J-Tg(Nkx2.1-Cre)2Sand/J provided by S. Anderson, Weill Cornell Medical 
College) (15).  F1 heterozygotes (Nkx2.1-Cre;Leprfl/+) were intercrossed to create an F2 
generation of LeprNkx2.1KO mice and Leprfl/fl control mice.  Mice were tail-tipped at 18-20 
days of age and genotyped using PCR on genomic DNA using the following primers:  
Cre 5’-GCGGTCTGGCAGTAAAAACTATC-3’ (forward);  
Cre 5’-GTGAAACAGCATTGCTGTCACTT-3’ (reverse);  
Lepr 5’-GTCTGATTTGATAGATGGTCTT-3’ (forward);  
Lepr 5’-AGAATGAAAAAGTTGTTTTGGGA-3’ (forward); 
Lepr 5’-ACAGGCTTGAGAACATGAACAC-3’ (reverse).   
Paired-feeding paradigm.  Mice were weaned at 3weeks and chow was provided in 
custom-made stainless steel feeding baskets that minimized spillage (Dieter Wenzel; 
Detmold, Germany).  Food intake was measured daily by weighing the baskets.  Pair-fed 
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(PF) groups were provided with the same amount of food consumed by controls the day 
before (1/3 of the amount in the morning and 2/3 at night).  Adiposity levels at weaning 
were used as a guide to ensure that ad libitum and pair-fed groups would be evenly 
matched.  For the adult caloric restriction (CR) challenge, 13 week old mice that had 
been previously fed ad libitum were restricted by 64-75% to achieve a 15% weight loss 
over a 2-week period, after which point they were either released to ad libitum feeding or 
sacrificed (KO-adult CR group, Figure 2.1). In other cohorts, paired-feeding was initiated 
either at 3 weeks or at 5 weeks of age and maintained until sacrifice at 10 weeks of age 
(PF3wk and PF5wk groups, respectively, Figure 2.1).  Some cohorts of males and females 
that were PF from 3 weeks were released to ad libitum feeding at 10 weeks and sacrificed 
at 18-20wks (8-10wks after release to ad libitum feeding)( KO-PF→AL groups, Figure 
2.1).  Mice were excluded from the study if they could not properly eat out of the feeding 
baskets.  Experimenters were not blinded to experimental groups of animals.  
In vivo measurements.  Mice were weighed 3 times per week.  Body composition was 
assessed on a weekly or bi-weekly basis using nuclear magnetic resonance imaging 
(Minispec, Bruker).  Naso-anal length was measured on anesthetized animals (4% 
isoflurane) biweekly.  Starting at 9wks and 17wks of age, oxygen consumption, carbon 
dioxide production, food intake and locomotor activity were measured simultaneously for 
a week using a 16-cage, Indirect Calorimetry System combined with Feeding Monitor 
and TSE ActiMot system (TSE-Systems).  Metabolic cage data were obtained from KO-
adult CR mice over 10 days.  Measurements from the first 24h were discarded.  Resting 
energy expenditure was calculated by averaging heat of each individual mouse when their 
locomotor activity was <10 total beam breaks (x and y directions combined) per minute. 
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Preservation of brown adipose tissue.  On the day before sacrifice, mice were subjected 
to an overnight fast at room temperature.  On the morning of sacrifice, mice were 
anesthetized using 2.5% Avertin (0.02mL/g i.p.) before undergoing a terminal bleed 
(serum) and cervical dislocation.  Brown adipose tissue was collected and portions were 
preserved in the following ways: All Protect (for gene expression)(Qiagen), in Z-fix (for 
histology) or in 4% paraformaldehyde, 0.08% gluteraldehyde for 4 hours and then 
overnight in 4% paraformaldehyde (for electron microscopy (EM)).  Tissues for EM were 
transferred to 0.1M phosphate buffer the following day and sent to Yale University for 
processing.  Samples used for tyrosine hydroxylase protein quantification were flash 
frozen in liquid nitrogen and stored in -80˚C freezer until used. 
Brown adipose tissue morphology.  Z-fixed brown adipose tissue was paraffin-
embedded and 5µm sections were stained with hemotoxylin and eosin (H&E).  Images 
were acquired at 10x and 20x magnification using a Nikon Eclipse 80i equipped with a 
Retiga EXi camera.  Lipid droplet size and number were calculated using Image J 
software (NIH).  At least 2 images per mouse and at least 3 mice per group were 
analyzed.   
Electron microscopy analysis of brown adipose tissue.  Brown adipose tissue samples 
were fixed in 4% paraformaldehyde, 0.1% glutaraldehyde in 0.1M phosphate buffer (PB, 
pH 7.3) for 1h.  They were washed several times in PB followed by post-fix in 1% OsO4 
for 30min, then dehydrated through increasing concentrations of alcohol (the 70% 
ethanol contained 1% uranyl acetate) followed by propylene oxide.  Samples were 
embedded in Durcupan and then sectioned (70 nm) using a Leica Ultracut 
ultramicrotome.  The sections were placed on formvar coated grids and examined under 
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an FEI BioTwin electron microscope equipped with an AMT XR16 camera. Pictures 
were taken at a direct magnification of 4800x.  
Brown adipose tissue gene expression.  We isolated total RNA using the RNeasy 
Universal Mini kit (Qiagen) and synthesized cDNA using Transcriptor First Strand 
cDNA Synthesis kit (Roche).  We used a LightCycler 480 SYBR Green I Master System 
(Roche) in quantitative PCR experiments. We normalized the expression of target genes 
against b-actin.  Primer sequences are provided in Supplemental Table 2.1. 
Measurement of glucose, leptin, free T3 and free T4.  All blood samples were 
collected between 10am and 12pm. Fasting blood samples were obtained from mice 
following 16h of fasting with ad libitum access to drinking water.  Blood was collected 
by orbital sinus puncture in isoflurane-anesthetized mice.  The blood was allowed to clot 
for 1h and then centrifuged at 3000g for 15min.  Serum was decanted and stored at -20˚C 
until used in leptin (Millipore) or fT3/fT4 analysis (Leinco Technology, Inc) ELISAs, per 
the manufacturer’s protocol.  Whole blood for glucose levels were taken via tail-nick on 
unanaesthetized mice and measured using a glucometer with disposable test strips 
(Abbott).  A “HI” reading was given a value of 501mg/dl.  Glucose tolerance tests (2g/kg, 
i.p. D-glucose) were administered at 5wks after an overnight fast.  Whole blood glucose 
was assayed via tail nick at baseline, and 30, 60, 90, and 120 minutes after injection. 
Protein analysis:  Brown adipose tissue proteins were extracted in RIPA buffer 
(ThermoFisher Scientific) with the addition of protease and phosphatase inhibitors 
(ThermoFisher Scientific).  Protein quantification was performed via the Pierce BCA 
protein assay kit (ThermoFisher Scientific).  Western blotting was performed using 30µg 
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of protein from each sample, and polyacrylamide gel electrophoresis was performed 
using a 10% Tris-glycine gel.  Tyrosine hydroxylase was detected using tyrosine 
hydroxylase antibody (Millipore) normalized to b-actin (Abcam), both primary antibodies 
were incubated at 4˚C overnight.  Fluorescent secondary antibodies were used (Rockland, 
LI-COR) for fluorescent imaging such that each primary antibody was detected in a 
different channel.  Fluorescence was measured via Odyssey v3.0 imaging program. 
Statistical Analysis:  Data are presented as group mean ± SEM.  Pilot experiments were 
used to determine initial statistical power.  Power analysis was performed post-hoc for 
subsequent experimental data.  We performed statistical comparisons between 2 groups 
using an equality of variance test, and then performing Student’s or Welch’s t-test 
accordingly. We performed statistical comparisons between multiple groups using a one-
way ANOVA, followed Fisher’s PLSD post-hoc analysis. Data using percentages were 
transformed using arcsine transformation, before performing a one-way ANOVA and 
post-hoc test.  We considered a P value of 0.05 or less to be statistically significant.  
Statistical significance was determined using StatView statistical software.  
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RESULTS 
Compensatory decrease in energy expenditure in weight-reduced adult KOs 
We first assessed the response of mature KOs to a 15% reduction in body weight, a 
condition known to elicit a compensatory decrease in energy expenditure in humans and 
rodents (8, 16).  To this end, we compared energy expenditure in 13-week-old male KOs 
at baseline and after weight loss was achieved by restricting caloric intake by 25-35% for 
a 2 week period (Figure 2.2A).  All weight-reduced KOs exhibited lower resting energy 
expenditure (REE) (Figure 2.2B), which likely contributed to rapid weight regain 
following release to ad libitum feeding (Figure 2.2A).  The 33.4% decrease in REE was 
also reflected in a 46.5% decrease in the expression of uncoupling protein 1 (Ucp1) 
mRNA in brown adipose tissue (BAT), the mitochondrial protein responsible for 
thermogenesis in this organ (17, 18) (Figure 2.2C).   Decreased energy expenditure was 
not associated with a change in expression levels of the mRNA encoding deiodinase 2 
(Dio2) in BAT, which can enhance adrenergic stimulation of Ucp1 expression by 
converting the inactive form of thyroid hormone (thyroxine - T4) to the active form 
(triiodothyronine -T3) (19) (Figure 2.2C).   
 
Young KOs increase energy expenditure after caloric restriction due to improved 
BAT function  
Next we examined whether weight loss achieved by caloric restriction at a young age 
might not be accompanied by the compensatory decrease in energy expenditure that is 
always seen in adults.  KO males were pair-fed to the intake of control littermates (CON) 
from weaning at 3 weeks through 10 weeks of age, corresponding to a ~36% reduction in 
	   64	  
daily caloric intake (KO-PF3wk group in Figure 2.1).  To compare energy expenditure in 
pair-fed (KO-PF3wk) and ad libitum-fed (KO-AL) KOs at 10 weeks of age, we first 
generated a regression equation relating REE, as measured by indirect calorimetry (TSE 
Systems), to fat mass and lean mass in KO-ALs.  We then calculated differences in REE, 
or “residuals”, between the two groups by comparing the actual energy expenditure in 
KO-PF3wk to predicted values of KO-ALs (20-22).   
 
In contrast to what we observed in weight-reduced adults, KO-PF3wk males at 10 weeks 
expended 37.8% more energy than predicted for a KO-AL of the same body composition 
(Figure 2.3A). This increase was not accompanied by increased locomotor activity 
(Figure 2.3B).  Next we measured circulating concentrations of free T3 (fT3), the active 
form of thyroid hormone that usually correlates closely with basal metabolic rate in 
rodents (23) and its prohormone, fT4.  To minimize confounding effects of different 
feeding patterns on thyroid hormone levels in PF and AL mice, measurements were taken 
after an overnight fast.  While serum concentrations of fT4 were similar in the two 
groups, levels of fT3 were 37% higher in KO-PF3wk males (Figure 2.3C).  These 
observations support the idea that there is a period of time in young animals when weight 
loss is not inextricably followed by a compensatory decrease in energy expenditure.  
 
Decreased oxygen consumption of BAT in LepR-deficient mice and rats (db/db and fa/fa, 
respectively) is associated with an increase in unilocular adipocytes at the expense of 
multilocular adipocytes and reduced expression of the thermogenic gene Ucp1 (24, 25). 
Thus, we examined whether increased energy expenditure of KO-PF3wk mice is 
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accompanied by improvements in these endpoints.  Whereas BAT of 10 week-old 
controls was largely comprised of multilocular adipocytes with small lipid droplets 
(<200µm2) (Figure 2.3E), KO-AL mice had 73.7% fewer small lipid droplets, and a 
corresponding increase in medium (201-1000µm2) and large (>1000µm2) lipid droplets 
(Figure 2.3F, H-J).  At the end of the PF period, the BAT of KO-PF3wk mice contained 
fewer medium-sized lipid droplets and a trend toward more small-sized droplets (Figure 
2.3G, H-J).  The shift toward a more multilocular organization of BAT in KO-PF3wk mice 
was accompanied by increased expression of Ucp1 (131%, p<0.01) and Dio2 (138%, 
N.S.)(Figure 2.3D).  These observations are consistent with the idea that improved BAT 
structure due to restricted feeding underlies the increased Ucp1 expression and energy 
expenditure of KO-PF3wk mice.  
 
Persistent increases in energy expenditure and reduced adiposity  
As changes in the activity of thermogenic circuits in the peri-weaning period lead to 
persistent increases in thermogenic capacity (26, 27), we examined whether improved 
BAT function and increased rates of REE in KO-PF3wk males could be stably maintained.  
To this end, we assessed body composition, metabolic and BAT phenotypes in KO-PF3wk 
males that were released to ad libitum feeding from 10-20 weeks of age (KO-PF→AL 
group in Figure 2.1).  REE of KO-PF→AL males was 15.3% higher than KO-AL 
littermates at 20 weeks (Figure 2.4A) and was not due to increased locomotor activity 
(Figure 2.4B).  Similarly, serum levels of fT3 were 41% higher in KO-PF→AL mice, 
while circulating concentrations of fT4 were not significantly different (Figure 2.4C).  
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Consistent with previous reports (28), the number of small multilocular adipocytes was 
stable from 10-20 weeks in all groups (Figure 2.4E-H).  In KO-AL mice, there was a 
trend toward an increase in the number of large lipid droplets at the expense of medium 
droplets (1059 medium vs. 80 large at 10 weeks; 748 medium vs. 87 large at 20 
weeks)(Figure 2.4I-J).  Conversely, the number of large droplets was significantly lower 
in KO-PF→AL mice at 20 weeks (Figure 2.4J).  In parallel with persistent effects of 
early PF on BAT morphology, expression of thermogenic genes trended higher in BAT 
of PF→AL mice (increases of 68.3% in Ucp1 and 84.3% in Dio2), although these 
differences did not reach significance (Figure 2.4D).  These findings are reminiscent of 
reports that interventions in young leptin-deficient ob/ob mice programmed lasting 
improvements in BAT morphology and thermoregulatory activity (29). 
 
We next assessed whether lasting increases in REE due to caloric restriction from a 
young age were also reflected in improved obesity-related endpoints in KO-PF→AL 
mice at 20 weeks in both males (Figure 2.5) and females (Supplemental Figure 2.1).  In 
response to reduced caloric intake, KO-PF3wk mice initially defended the same elevated 
levels of adiposity as seen in KO-ALs at the expense of lean mass deposition (Figure 
2.5A-C, Supplemental Figure 2.1A-C), similar to observations in LepR-deficient mice 
and rats (30, 31).  In contrast to pair-fed global LepR knockouts, the adiposity of KO-
PF3wk males and females diverged from KO-AL littermates at 6 weeks of age and were 
stably maintained, such that they were 18.9% lower at the end of PF in males (Figure 
2.5A) and 14.9% lower at the end of PF in females (Supplemental Figure 2.1A).   
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After release to ad libitum feeding, KO-PF→AL mice rapidly increased food intake, 
reaching KO-AL levels within 1 week of ad libitum feeding (Figure 2.5).  Increased food 
intake was immediately followed by increases in lean mass deposition and body weight.  
Lean mass reached KO-AL levels within 3 weeks of ad libitum feeding, while body 
weight caught up more gradually (Figure 2.5).  However, they maintained stable levels of 
adiposity through 20 weeks (Figure 2.5).  Consistent with reduced adiposity, serum leptin 
levels were 47.5 and 35.8% lower in KO-PF→AL males at 11-12 weeks and 19-21 
weeks, respectively (Supplemental Figure 2.2).  While fed and fasting levels of blood 
glucose were reduced by caloric restriction, GTTs in KO-PF mice at 5 weeks of age were 
not improved by reduced food intake, consistent with the critical role for hypothalamic 
LepR signaling in circuits regulating glucose homeostasis (32) (Supplemental Figure 
2.3).  Reductions in random-fed blood glucose levels of KO-PF3wk males during paired-
feeding did not persist after release to ad libitum feeding, consistent with the idea that 
increased caloric intake is a major driver of hyperglycemia in the fed state (Supplemental 
Figure 2.3).  In conclusion, restricted feeding from a young age programmed lasting 
improvements in BAT morphology and activity, promoting deposition of lean mass at the 
expense of fat mass during the period of rapid growth that followed release to ad libitum 
feeding. 
 
Reduced caloric intake improves BAT mitochondrial structure regardless of age 
Dense packing of cristae within mitochondria is correlated with metabolic output of BAT 
(33, 34).  Conversely, distorted organization of cristae has been proposed to underlie 
deficits in BAT thermogenesis observed in genetic models of obesity (24, 35, 36).  We 
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performed electron microscopy to examine whether improved mitochondrial organization 
contributed to enhanced BAT function in KO-PF3wk mice at the end of PF (10 weeks) and 
after release to ad libitum feeding (20 weeks).  As expected, lean controls exhibited 
tightly-packed cristae at 10 and 20 weeks (Figure 2.6A,F), while 26.1% and 17.4% of 
KO-AL mitochondrial cristae at 10 weeks and 20 weeks, respectively, formed loops, 
branches or other abnormal configurations (Figure 2.6B,E,G).  Paired-feeding from 
weaning reduced the percent of abnormal cristae by 65.8% (Figure 2.6C,E) and produced 
marked improvements in mitochondrial organization that persisted even after release to 
ad libitum feeding (Figure 2.6H). In conjunction with improved mitochondrial structure, 
expression of BAT mitochondrial genes was higher in KO-PF3wk mice than in KO-AL 
mice at both 10 and 20 weeks (Figure 2.6L,M). 
 
We next considered whether the failure to observe increased energy expenditure in KO 
mice that were calorically-restricted in adulthood (KO-Adult CR group in Figures 2.1 and 
2.2), reflected a failure to impact mitochondrial structure.  After 2 weeks of CR, 
mitochondrial organization was markedly improved, as reflected in increased density of 
cristae (8.6±.64 KO-AL vs. 12.5±1.8 KO-Adult CR, p<0.05) and presence of fewer 
abnormal cristae (17.5% KO-AL vs. 6.6% KO-Adult CR, p<0.05)(Figure 2.6I-K).  
Despite the dramatic improvement in mitochondrial organization produced by caloric 
restriction in adult KOs, expression of mitochondrial genes was generally unchanged or 
reduced (Figure 2.2C, 2.6N), consistent with compensatory decreases in energy 
expenditure in the weight-reduced state (Figure 2.2B).  While restoring densely-packed 
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cristae in KOs likely increases the capacity of BAT to respond to thermogenic stimuli, it 
is not sufficient to normalize BAT thermogenic activity.   
 
The peri-weaning period is a critical window for intervention 
Studies in diet- and genetically-induced obese models support the idea that the ability to 
normalize body weight and adiposity declines with age (37-40).  As diminished efficacy 
of interventions can be observed within a few weeks of weaning (38, 39), we assessed 
metabolic responses of KOs to paired-feeding that was initiated at 5 weeks (KO-PF5wk 
group in Figure 2.1).  We found that REE in roughly half of KO-PF5wk males was higher 
than KO-ALs at 10 weeks (Figure 2.7A, black bar), similar to the aggregate response 
observed in KO-PF3wk males (Figure 2.3A).  The remainder of the group exhibited 
decreased energy expenditure (Figure 2.7A, white bar), similar to the response of adults 
to acute weight loss (Figure 2.2B).  Increased REE in a subset of KO-PF5wk mice 
correlated with a trend toward higher serum fT3 levels as compared to age- and exposure-
matched KO-PF5wk mice that decreased REE in response to PF (Figure 2.7B).  Moreover, 
mice that increased REE in response to PF gained significantly less adiposity during the 
PF period than those that decreased REE (8.3% vs. 26.6%, P=0.01)(Figure 2.7C).  This 
inverse relationship between REE and percent adiposity gained was maintained across 
the cohort of mice that were PF from 5 weeks (Figure 2.7D).  Thus, 5 weeks of age likely 
represents the outer limit of the critical period for weight loss interventions that do not 
necessarily involve compensatory reduction in REE in our model.  These findings are 
reminiscent of bimodal responses of children to weight loss, as well the relationship 
between increased fT3 levels and successful weight loss maintenance (11).  
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DISCUSSION  
We utilized a mouse model of genetically-induced hyperphagia and obesity to study why 
weight loss interventions in younger obese children produce better outcomes than in older 
adolescents and adults (41-43). The KO mice exhibited developmental deficits in BAT 
activity and resting energy expenditure, creating a vicious cycle that further exacerbates 
obesity.  Caloric restriction at any age improved BAT structure and capacity (Figure 2.6), 
consistent with reports in other genetic models of obesity (44-46).  The key difference 
between early vs. late intervention was that weight loss before 5 weeks was also 
accompanied by increased fT3, BAT activity, and energy expenditure (Figures 2.3 and 
2.4), while intervention afterward was associated with decreases in these endpoints 
(Figure 2.2).  The extent to which decreases in adiposity were stably maintained in males 
after 10 weeks of ad libitum feeding (19%, Figure 2.5), is similar to the 20-23% reduction 
achieved by bariatric surgery in adult mice (47, 48). 
 
Our observations are reminiscent of reports that weight loss in some children is not 
necessarily followed by reduced fT3 (11), while reduced fT3 is nearly always observed in 
weight-reduced teens (49) and adults (9).  As failure to exhibit reduced fT3 in the weight-
reduced state was associated with better weight loss maintenance (11), it supports the 
idea that our mouse model of early-onset obesity can provide novel mechanistic insights 
into temporal and molecular determinants of efficacious weight-loss strategies in 
children. 
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Early-onset hyperphagia and obesity lead to developmental deficits in mitochondrial 
structure and BAT activity 
Decreased energy expenditure in genetically obese rodents precedes the onset of 
hyperphagia and contributes to increased adiposity (50-54).  Cristae malformations that 
impair mitochondrial function in these models (34, 55) are closely correlated with 
decreased energy expenditure (24, 35, 36).  Thus, it has been proposed that impaired 
BAT mitochondrial structure reduces the capacity to respond to cold or sympathetic 
signals, leading to decreased rates of thermogenesis (24, 36, 56-59).  Sympathetic signals 
that activate BAT are also lower in genetically obese mice, and thus could further reduce 
BAT output (60-63). 
 
While endpoints related to energy expenditure are rarely examined in human adolescents, 
several studies reported that BAT activity (64-66) and REE (10) are higher than in adults.  
Failure to develop robust BAT activity in adolescents is associated with increased BMI 
and adiposity (65, 67), similar to what is found in rodent models (current study and (50, 
68, 69)).  These observations are consistent with the idea that early impairments in BAT 
structure and function underlie observations that childhood obesity is often established 
within the first few years of life (70, 71).   
 
Increasing BAT capacity and activity reduces adiposity in obese mouse models 
We observed that KO mice at 10 weeks have more abnormal cristae per mitochondrion as 
compared to lean control littermates, which is largely reversed by paired feeding (Figure 
2.6).  While paired feeding in ob/ob mice also enhances BAT mitochondrial structure and 
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capacity, leptin-deficient mice exhibit increased adiposity - the opposite of what is 
observed in KO-PFs.  Combining paired feeding with administration of an exogenous 
BAT activator, such as T3, leads to reduced adiposity in ob/ob mice (72).  These 
observations support the idea that there is thermogenic activator that is disrupted in 
global leptin knockouts, but is preserved in KO-PFs.   
 
In theory, reductions in BAT-activating signals in ob/ob mice could be caused directly by 
deficits in leptin signaling and/or secondary effects of hyperphagia and increased 
circulating levels of glucose that accompany the transition to a carbohydrate-based diet at 
weaning.  As we do not observe reductions in adiposity in pair-fed KOs until 6-7 weeks 
of age, despite the fact that mice have been consuming less food since weaning at 3 
weeks, it is likely that factors independent of diet are the primary drivers of increased 
energy expenditure.  The idea that BAT thermogenesis directly contributes to the 
metabolic improvements in KO-PFs is supported by the fact that reduced adiposity is first 
detected at 6-7 weeks of age, the same time that this strain develops the capability to 
mount a thermogenic response to cold (13, 73).  It is not likely that “browning” or white 
adipose depots significantly contributes to metabolic benefits of paired feeding, as we did 
not detect Ucp1 expression in gonadal or inguinal depots of KO-PFs (data not shown – 
please refer to Appendix I).  Thus, we hypothesize that the ability of paired feeding to 
reduce adiposity in the conditional KOs stems from increased endogenous activation of 
BAT thermogenesis via LepR-mediated signals that are not impacted by Nkx2.1-Cre-
mediated recombination ((13, 15), as discussed in (73)).  The failure to detect an increase 
in tyrosine hydroxylase protein content in BAT, a surrogate for sympathetic tone (74) 
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(Supplemental Figure 2.5), raises the possibility that the factors responsible for increased 
thermogenesis in KO-PFs are not sympathetically driven.  Determining whether any of 
the growing list of adrenergic-independent brown fat activators (75) are involved is an 
important area for future study. 
 
Hypothalamic leptin signals influence sympathetic outflow to BAT (76, 77) and function 
of the thyroid axis (13).  Therefore, it is possible some features of the mechanism driving 
increased energy expenditure in KO-PFs may be uniquely activated in this model, or may 
also apply to other situations involving congenital deficits in thermoregulatory and/or 
thyroid function.  Reports that leptin’s ability to reduce adiposity independent of food 
intake is dependent on BAT thermogenesis (78), is consistent with the possibility that 
some of the underlying signaling pathways will be shared.  Ascertaining the 
generalizability of these findings is an important area for future research, but is hampered 
by the lack of mouse models with intact leptin signaling pathways that exhibit 
pronounced obesity before the end of the critical period at 5 weeks.  Even if the pathways 
responsible for increased REE in KO-PFs are unique to this model, evidence that patterns 
of BAT innervation and activity are programmed during the peri-weaning period (27, 79) 
supports the idea that the time window for efficacious interventions in obesity is before 
puberty. 
 
Working model (Figure 2.8) 
In adolescent children (65, 67) and mouse models (current study and (50, 57, 68, 69)), the 
failure to develop robust BAT thermogenic activity leads to increased adiposity.  We 
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hypothesize that the paradoxical increase in fT3 and REE in young weight-reduced mice 
or humans stems from improved mitochondrial structure and enhanced capacity to 
respond to stimuli that are circulating at high levels during adolescence.  Patterns of 
increased BAT activity and rates of REE resulting from early intervention are 
permanently programmed (27, 79), as they persist even after KO-PFs resume overeating. 
In contrast, any improvements in BAT capacity after adolescence (KO-CR) would be 
negated by compensatory decreases in sympathetic tone (9, 80-82), the primary driver of 
BAT activity in the adult rodent (83).  If our model is correct, impacts of interventions 
that enhance BAT capacity in time to respond to factors driving the peak of BAT activity 
during adolescence could explain observations that intervention in pre-pubertal children 
has higher success rates (41-43).   
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FIGURES 
Figure 2.1. Experimental groups.  Control and KO-AL groups were fed ad libitum 
throughout the study.  Adult CR mice were fed ad libitum from 3-13 weeks, then 
calorically restricted from 13 to 15 weeks of age.  KO-PF3wk mice were pair-fed from 3-
10 weeks of age, while paired feeding was started at 5 weeks of age in KO-PF5wk mice.  
KO-PF→AL mice were pair-fed from 3-10 weeks of age and then released to ad libitum 
feeding for at least 8 weeks. 
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Figure 2.2. Decreased energy expenditure in adult LepHYPKOs (KO) following 
weight loss.  A) Percent weight change during caloric restriction (CR) and after release to 
ad libitum feeding.  B) Resting energy expenditure before CR (Pre-CR) and at the end of 
the 2-week period of CR (Post-CR).  C) Relative expression levels of Ucp1 and Dio2 in 
BAT from ad libitum-fed KOs (white bars) vs. KOs after 2wk CR (black bars).  Error 
bars represent SEM.  * represents p<.05, paired t-test.  For gene expression, data were 
tested for equality of variance, and p-values were determined by Student’s t-test.  Data 
were generated from n=8 per group from 2 independent cohorts for energy expenditure 
and n=4-6 per group from 1-2 cohorts for gene expression.  
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Figure 2.3.  Paired-feeding results in increased energy expenditure due to improved 
BAT function.  (A-D) Energy expenditure-related phenotypes at 10 weeks of age, the 
end of the PF period, in ad libitum-fed KOs (white bars) vs. pair-fed KOs (black bars).  
(A) Resting energy expenditure. (B) Locomotor activity.  (C) Serum levels of free T3 and 
free T4.  (D) Relative expression levels of Ucp1 and Dio2 in BAT.  (E-G) BAT 
morphology revealed by H&E staining in ad libitum-fed controls (E), ad libitum-fed KOs 
(F) and pair-fed KOs (G) taken at 20x magnification, scale bar represents 100µm.  (H-J) 
Quantification of small (<200µm2)(H), medium (201-1000µm2)(I), and large 
(>1001µm2)(J) lipid droplets in BAT from controls (hatched bars), ad libitum-fed KOs 
(white bars) and pair-fed KOs (black bars).  Error bars represent SEM.  * represents 
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p<.05, ** represents p<.01.  (A-D) Data were tested for equality of variance, and p-values 
were determined by either Student’s or Welch’s t-test accordingly.  (H-J) P-values were 
determined by ANOVA and post-hoc Fisher’s LSD.  Letters (a,b,c) represent differences 
between groups.  Data were generated from: n=5-10 per group from 1-2 independent 
cohorts for REE; 3-4 per group from 1 cohort for locomotor activity; 3-9 per group from 
1-2 independent cohorts for fT3; 3-4 mice from 1 cohort for fT4; n=3-11 per group from 
2 independent cohorts for gene expression.  Lipid droplet quantification was performed 
on n=3-5 per group from 1 cohort. 
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Figure 2.4.  Improvements in energy expenditure and BAT morphology persist into 
adulthood.  (A-D) Energy expenditure-related phenotypes at 17-20 weeks of age, after 
several weeks on ad libitum feeding, in KOs that were always fed ad libitum (white bars) 
vs. KOs that were previously pair-fed (black bars).  (A) Resting energy expenditure. (B) 
Locomotor activity.  (C) Serum levels of free T3 and free T4.  (D) Relative expression 
levels of Ucp1 and Dio2 in BAT.  (E-G) BAT morphology revealed by H&E staining in 
ad libitum-fed controls (E), ad libitum-fed KOs (F) and previously pair-fed KOs (G) 
taken at 20x magnification, scale bar represents 100µm.   (H-J) Quantification of small 
(<200µm2)(H), medium (201-1000µm2)(I), and large (>1001µm2)(J) lipid droplets in 
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BAT from ad libitum-fed controls (hatched bars), ad libitum-fed KOs (white bars) and 
previously pair-fed KOs (black bars).  Error bars represent SEM.  * represents p<.05, ** 
represents p<.01.  (A-D) Data were tested for equality of variance, and p-values were 
determined by either Student’s or Welch’s t-test accordingly.  (H-J) P-values determined 
by ANOVA and post-hoc Fisher’s LSD.  Letters (a,b,c) represent differences between 
groups.  Data were generated from: n=6-7 per group from 2-3 independent cohorts for 
REE; n=3-6 per group from 1 cohort for locomotor activity; n=6-11 per group from 3 
independent cohorts for fT3; n=3-9 per group from 1-2 independent cohorts for fT4; n=6-
11 per group from 3-4 cohorts for gene expression.  Results from lipid droplet analysis 
are based on analyses of n=4-6 per group from 1-2 independent cohorts. 
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Figure 2.5.  Paired-feeding of KO mice at an early age results in persistent changes 
in body weight and adiposity.  Percent body fat (A), body weight (B), naso-anal length 
(NAL) (C), and food intake (D) in ad libitum-fed controls (dashed line) vs. ad libitum-fed 
KOs (medium-thickness line with white circles) vs. KOs that were pair-fed from 3-10 
weeks of age (thick line). P values were determined by ANOVA and post-hoc Fisher’s 
LSD.  * represents p<.05 between AL and PF group, # represents p<.05 between PF and 
CON groups, and + represents p<.05 between AL and CON groups.  Data were generated 
from n=4-20 per group from 4-5 independent cohorts. 
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Figure 2.6.  Caloric restriction at any age improves BAT mitochondrial structure.  
Electron micrographs of BAT at 10 weeks of age (A-C) and in adults (F-I). Scale bar 
represents 500nm.  Images were used to calculate average number of cristae per 
mitochondrion (D, J) and the percent of abnormal cristae (E, K) in ad libitum-fed controls 
(A, F, hatched bars), ad libitum-fed KOs (B, G, white bars), KOs pair-fed from 3-10 
weeks of age (C, H, black bars) and KOs that were exposed to CR in adulthood (I, 
diagonal stripes). (L-N) Relative expression levels mitochondrial genes in BAT at 10 
weeks (KO-AL vs. KO-PF) (L), 20 weeks (KO-AL vs. KO-PF) (M), and following CR in 
adulthood (KO-AL vs. KO-Adult CR) (N).  P-values for mitochondrial analyses were 
determined by ANOVA and post-hoc Fisher’s LSD.  P-values for % abnormal cristae 
were determine by performing arcsine transformation prior to an ANOVA and post-hoc 
test.  P-values for gene expression were determined by first performing an equality of 
variance test, then performing Student’s or Welch’s t-test accordingly.  Data were 
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generated from: n=3-4 per group at 10 weeks from 1 cohort; n=3-6 adults per group at 20 
weeks from 1-2 independent cohorts; n=5 KO-adult CR per group from 2 independent 
cohorts. 
 
Figure 2.7.  There is a critical time period in which to intervene.  Physiological 
phenotypes of KO mice that decreased energy expenditure following PF from 5 weeks of 
age (white bars) vs. mice that increased energy expenditure (black bars).  (A) Resting 
energy expenditure.  (B) Serum free T3.  (C) Percent change in body fat from 3-10 
weeks.  (D) Regression of resting energy expenditure vs. percent change in adiposity.  
Each symbol in B corresponds to an individual mouse.  P-values were determined by 
performing an equality of variance test, then performing Student’s or Welch’s t-test 
accordingly.  Data were generated from n=13 per group from 3 independent cohorts. 
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Figure 2.8. Working hypothesis to explain temporal differences in the metabolic 
response of obese KO mice to weight loss.  Caloric restriction improves BAT 
mitochondrial structure in young (KO-PF) and adult (KO-CR) KOs.  When interventions 
are initiated before 5 weeks of age, enhanced BAT responsiveness to factors that promote 
activity in adolescence (indicated by a lightning bolt)  drive increases in energy 
expenditure that are stably maintained.  After the peak of BAT activity in adolescence, 
weight loss-induced improvements in BAT capacity are opposed by compensatory 
decreases in sympathetic tone. 
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SUPPLEMENTAL FIGURES 
 
Supplemental Figure 2.1:  Paired-feeding of female KO mice at an early age results 
in persistent changes in body weight and adiposity.  Percent body fat (A), body weight 
(B), naso-anal length (NAL) (C), and food intake (D) in ad libitum-fed controls (thin line) 
vs. ad libitum-fed KOs (medium-thickness line with white circles) vs. KOs that were 
pair-fed from 3-10 weeks of age (thick line). P-values were determined by ANOVA and 
post-hoc Fisher’s LSD.  * represents p<.05 between AL and PF group, # represents p<.05 
between PF and CON groups, and + represents p<.05 between AL and CON groups.  
Data were generated from n=7-10 per group from 3 independent cohorts. 
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Supplemental Figure 2.2:  Lasting impact of paired-feeding on serum leptin levels.  
Serum leptin levels at 4, 8, 11-12, 14, and 19-21 wks in ad libitum-fed controls (hatched 
bars), ad libitum-fed KOs (white bars) and KOs pair-fed from 3-10wks (black bars).  
Statistical difference calculated by ANOVA and post-hoc Fisher’s LSD.  Letters (a,b,c) 
represent differences between groups.  Data were generated from n=3-10. 
  
	  
	   87	  
Supplemental Figure 2.3:  Improvements in glucose homeostasis during paired-
feeding are not maintained.  Blood glucose levels in ad libitum-fed control (hatched 
bars, thin line), ad libitum-fed KOs (white bars, medium lines with white circles) and 
KOs pair-fed from 3-10wks (black bars, thick line).  (A) Random-fed (am) blood glucose 
levels at 4, 8, 11, 14, 19wks.  (B) Glucose tolerance test in fasted mice at 5wks.  
Statistical differences were calculated by ANOVA and post-hoc Fisher’s LSD. Letters 
(a,b,c) represent differences between groups.  # represents p<.05 between PF and CON 
groups, and + represents p<.05 between AL and CON groups.  Data were generated from 
n=3-9 per group from 1-2 independent cohorts for fed glucose; n=6-8 per group from 2 
independent cohorts for GTT. 
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Supplemental Figure 2.4: Serum fT3 levels decrease with age.  Serum fT3 levels in 10 
week (white bars) vs. 20 week (black bars) in control, KO-AL, and KO-PF mice.  Data 
generated from n = 5-11 mice from independent 2-3 cohorts. 
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Supplemental Figure 2.5: No change in sympathetic marker tyrosine hydroxylase 
during paired-feeding.  Relative protein expression of tyrosine hydroxylase in brown 
adipose tissue of ad libitum-fed KOs (white bars) and pair-fed KOs (black bar) at 13 
weeks of age.  Liver was used as a negative control.  (A) Average ratio of TH/β-actin 
protein expression.  (B) Representative gel from which data was generated.  No statistical 
differences were calculated using a two-tailed student’s t-test.  Data generated from n = 
3-6 from 1 cohort. 
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SUPPLEMENTAL TABLE 
Supplemental Table 2.1.  qPCR primers. 
 
Part II:  Concluding remarks: 
Based on our results, we determined that BAT is the thermogenic organ driving the 
metabolic phenotype of increased energy expenditure in our model of early intervention.  
This conclusion was made not only on data presented in the manuscript, but on exclusion 
of other metabolically relevant tissue, such as liver, inguinal adipose tissue, gonadal 
adipose tissue, brain.  Please refer to Appendix I for additional information. 
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CHAPTER 3: Influences of BAT Development Start in the 
Peri-weaning Period 
This work was completed with the help of Rim Hassouna, who helped generate data for 
female mice and serum IGF-1 assays and helped collect organs across all time points of 
the study.  
 
Note: The experiments within this chapter are still a work in progress. 
 
Part I: Current Data 
INTRODUCTION 
With the childhood obesity rate at nearly 17% within the United States (1), it is important 
to develop more efficacious strategies in combating this epidemic.  In Chapter 2 we 
reported that the age at which obesity intervention is implemented could determine 
success versus failure in a mouse model of early-onset hyperphagia and obesity.  We 
found that initiating caloric restriction at weaning produced sustained reductions in 
adiposity due to increased energy expenditure (EE), while interventions after 5 weeks of 
age were associated with compensatory decreases in EE (2).  Increased EE resulted from 
improvements in brown adipose tissue (BAT) capacity to respond to endogenous stimuli, 
but not in increased sympathetic tone (2).  Together with reports suggesting that deficits 
in BAT activity in children are linked to subsequent increases in adiposity (3-5), our 
findings raise the possibility that improving BAT capacity may be a therapeutic target for 
childhood obesity intervention. 
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Rodent development is highly compressed, as pubertal maturation is largely completed 
within a 4 week period after weaning.  Thus, the human correlate of the immediate post-
weaning period in mice, which was identified in our study as a critical time for 
intervention, likely spans infancy through early adolescence.  It is widely accepted that 
BAT plays an important role in maintaining thermogenesis in human infants (as 
discussed in (6, 7)).  BAT is first detected in the developing fetus at approximately 5 
months of gestation (8).  The distribution of brown adipocytes is maximal in infancy, 
detected mostly in the interscapular region (9), and begins to decline during childhood (9-
12).  BAT activity is critical during the early postnatal period to regulate body 
temperature at birth, as newborns do not shiver (9).  In childhood and early adolescents, 
the perirenal region is the most abundant classical BAT depot, which can also be present 
in lesser quantities in adults (11, 13, 14).  BAT thermogenic capacity, as defined by 
uncoupling protein 1 (UCP1) levels, declines between 6-9 months of age (9) leading to 
the longstanding assumption that BAT did not contribute to energy balance in adulthood.  
Later studies highlighted the relevancy of BAT in adults, and identified beige adipocytes 
in the supraclavicular region (13). 
 
The publication of 3 simultaneous studies in 2009, sparked the growing appreciation that 
brown adipocytes (or inducible beige adipocytes) can be activated in adults (6, 15, 16).  
These papers validated the use of 18F-fluorodeoxyglucose (FDG) positron emission 
tomography (PET) and computed tomography (CT) to quantify BAT activity.  Due to the 
involvement of radiolabeled tracers, there are few analyses of BAT activity in children.  
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Two groups performed retrospective analyses of BAT activity in children that received 
PET scans in the course of treatment for cancer.  Data from both studies are consistent 
with the idea that there is an expansion of BAT in the supraclavicular depot during 
childhood, with a peak activity occurring during puberty (3, 4).  Increased BAT mass in 
adolescents (as compared to patients under 10 years of age) is independent of 
environmental temperature and BAT activation status (4, 17).  In males, BAT activity 
peaks between 13-15 years of age and is 4-fold higher than levels in adults (3).  The peak 
of BAT activity is slightly later in females, 15-17 years of age, and is marked by a 3-fold 
increase over adult levels (3).  Similar to what is seen in adults, BAT activity can still be 
recruited upon cold stimulation after the decline of basal activity levels (6, 16, 18-20). 
 
Using the Nkx2.1-Cre;Leprfl/fl model of early-onset hyperphagia and obesity (hereby 
referred to as KO), we found that 5 weeks of age marks the end of the period when 
weight loss can be achieved without a compensatory decrease in EE (Chapter 2) (2).  
Most studies of BAT development in rodents focused on gestation and the neonatal 
period, when mitochondrial cristae are tightly packed and BAT capacity is maximal (21, 
22).  The equivalent phase of BAT recruitment and activation in the interscapular depot 
in humans is likely achieved within the first few months of life (9).  There is evidence 
that there is an expansion of BAT depots during childhood, which is followed by a peak 
of BAT activity in teens (3, 4).   
 
The primary goal of this study was to fill a critical gap in our knowledge of BAT 
development during the peri-weaning period in rodents, the likely equivalent of 
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childhood and early adolescence in humans.  To this end, we characterized the size of 
BAT depot in conjunction with markers of BAT capacity and activity from 2-13 weeks of 
age.  We found that an expansion in the size of the BAT depot between 2-3 weeks of age 
was accompanied by a dramatic decrease in BAT capacity and activity.  BAT activity 
increased across the first two post-weaning weeks, peaking at 5 weeks of age.  Since 
sympathetic tone does not correlate with energy expenditure during this period in rodents 
(23), we sought to identify neuroendocrine factors that might enhance BAT activity 
during this period.  Our initial efforts focused on insulin-like growth factor 1 (IGF-1), 
because the peak in BAT activity occurs at a similar time as the peak in serum IGF-1 
levels (3, 24).  Moreover, reports that IGF-1 promotes the differentiation, proliferation, 
and thermogenic activation of brown adipocytes in vitro (25-27), raise the possibility that 
IGF-1 also enhances BAT maturation during the post-weaning period in mice.  Finally, 
we explored whether the beneficial effects of paired-feeding on EE in the KO model are 
due to effects on maturation processes in the post-weaning period. 
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METHODS 
Mouse husbandry. Mouse husbandry was kept the same as in Chapter 2 (page 57). 
Generation of LeprHYPKO mice.  To disrupt LepRb signaling in the hypothalamus, mice 
homozygous for the floxed allele of Lepr (FVB.BKS(D)-Leprdb provided by S. Chua, 
Albert Einstein College of Medicine) (28) were crossed with the Nkx2.1-Cre driver line 
(C57BL/6J-Tg(Nkx2.1-Cre)2Sand/J provided by S. Anderson, Weill Cornell Medical 
College) (29).  F1 heterozygotes (Nkx2.1-Cre;Leprfl/+) were intercrossed to create an F2 
generation of LeprNkx2.1KO mice and Leprfl/fl control mice.  Genotyping performed was 
the same as described in Chapter 2 (page 57). 
Paired-feeding paradigm.  Paired-feeding was carried out as per the methods section in 
Chapter 2 (page 57).  Mice were sacrificed in the fed state at either 5 weeks or 13 weeks 
of age. 
Preservation of organs.  On the day before sacrifice, mice were brought to the 
laboratory overnight.  Mice were allowed ad libitum access to food unless otherwise 
specified.  On the morning of sacrifice, mice were anesthetized using 2.5% Avertin 
(0.02mL/g i.p.) before undergoing a terminal bleed (serum) and cervical dislocation.  
Brown adipose tissue was collected and half the depot was preserved in All Protect 
(Qiagen) for RNA quantification while the other half was flash frozen in liquid nitrogen 
for protein extraction. 3 week BAT samples were also collected in 4% paraformaldehyde, 
0.08% gluteraldehyde for 4 hours and then overnight in 4% paraformaldehyde (for 
electron microscopy (EM)).  Samples in All Protect were stored in the -20°C freezer, 
flash frozen samples were stored in the -80°C freezer.  Bone marrow was extracted from 
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the femur using cold PBS.  Bone marrow was centrifuged at 1500g for 5 minutes and the 
supernatant was discarded.  The pellet was re-suspended using Trizol and samples were 
stored in the -80°C freezer until later use.  Pituitary, hypothalamus, white adipose tissue 
depots and liver were stored in All Protect (Qiagen) and stored in the -20°C freezer.  
Electron microscopy analysis of brown adipose tissue.  Electron microscopy was 
performed by Tamas Horvath at Yale University using the same procedure as mentioned 
in Chapter 2 (page 59).  
Gene expression.  We isolated total RNA using the RNeasy Universal Mini kit (Qiagen) 
and synthesized cDNA using Transcriptor First Strand cDNA Synthesis kit (Roche).  We 
used a LightCycler 480 SYBR Green I Master System (Roche) in quantitative PCR 
experiments. We normalized the expression of target genes against b-actin. 
Measurement of free T3 and IGF-1.  All blood samples were collected at sacrifice and 
blood was allowed to clot for 1h and then centrifuged at 4500g for 10min.  Serum was 
decanted and stored at -20˚C until used in IGF-1 (Enzo) or fT3/fT4 analysis (Leinco 
Technology, Inc) ELISAs, per the manufacturer’s protocol.  
Protein analysis:  Proteins were extracted and quantified as describe Brown adipose 
tissue proteins were extracted in RIPA buffer (ThermoFisher Scientific) with the addition 
of protease and phosphatase inhibitors (ThermoFisher Scientific).  Protein quantification 
was performed via the Pierce BCA protein assay kit (ThermoFisher Scientific).  Western 
blotting was performed using 30µg of protein from each sample in AL-KO vs. control 
analysis, and polyacrylamide gel electrophoresis was performed using a 10% Tris-glycine 
gel.  AL-KO vs. AL-PF was performed using 15µg of protein from each sample.  UCP1 
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was detected using anti-UCP1 (Abcam) (1:4000 dilution) normalized to b-actin (Abcam) 
(1:20000 dilution), both primary antibodies were incubated at 4˚C overnight.  Fluorescent 
secondary antibodies were used (Rockland, LI-COR) for fluorescent imaging.  
Fluorescence was measured via Odyssey v3.0 imaging program. 
Statistical Analysis:  Data are presented as group mean ± SEM.  We performed 
statistical comparisons between 2 groups using an equality of variance test, and then 
performing Student’s or Welch’s t-test accordingly. We performed statistical 
comparisons between multiple groups using a one-way ANOVA, followed Fisher’s 
PLSD post-hoc analysis. Data using percentages were transformed using arcsine 
transformation, before performing a one-way ANOVA and post-hoc test.  We considered 
a p-value of 0.05 or less to be statistically significant.  Statistical significance was 
determined using Excel and GraphPad software.  
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RESULTS IN PROGRESS 
BAT capacity in lean mice decreases between 2-3 weeks of age 
First, we examined whether the high oxidative capacity and activity of neonatal BAT (21, 
26, 30) are maintained through lactation. To this end, we compared the expression of 
several genes related to BAT capacity and function between 2 to 3 weeks of age in lean 
mice.  We found that the expression of markers of BAT activity, such as Ucp1 and 
deiodinase 2 (Dio2), was reduced by 82.3% (p<.05) and 79.4% (p=.01), respectively 
(Figure 3.1A).  Additionally, expression of the gene encoding cytochrome c oxidase IV 
(CoxIV), the final step in the electron transport chain (31, 32), was reduced by 68.7% 
(p=.07) (Figure 3.1A).  Taken together, we found that 2 to 3 weeks of age is a time of 
impaired BAT oxidative capacity.  
 
It was previously reported that mitochondrial cristae formation and mitochondrial 
respiration are maximal in the first postnatal week (21).  Therefore, we next asked 
whether the decreased expression of markers of BAT activity was correlated with 
changes in mitochondrial structure.  Reductions in thermogenic gene expression in the 
BAT were accompanied by distorted mitochondrial structure (Figure 3.1B,C).  The BAT 
mitochondria at 3 weeks of age contained the same total number of cristae/mitochondrion 
as at 10 weeks of age (Figure 3.1D), but had more abnormal cristae/mitochondrion 
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The size of the BAT depot expands between 2-3 weeks of age 
As the initial period of BAT “unmasking” (33) and activation in human neonates is 
followed by a period of expansion in the size of the depot during childhood (4), we next 
asked whether a similar process occurs in rodents.  We found that BAT weight almost 
doubled in size from 2-3 weeks of age (0.043g ±.009, n=4 at 2 weeks vs. 0.08g ±.011, 
n=5 at 3 weeks)(p<.05) (Figure 3.2A).  After this initial expansion, BAT weight remained 
constant from 3 weeks of age into adulthood (Figure 3.2B).  In contrast, liver (Figure 
3.2C), inguinal adipose tissue (iFat) (Figure 3.2D), and gonadal adipose tissue (gFat) 
(Figure 3.2E) increased in weight from 3 to 5 weeks of age in parallel to total body 
weight.   
 
Evidence for a peak of BAT activity in lean mice at 5 weeks of age 
Since BAT capacity (as reflected in mitochondrial structure) was impaired at 3 weeks of 
age relative to 10 weeks of age (Figure 3.1B,C), we next determined when BAT activity 
is restored.  We found that BAT Ucp1 transcript levels increased by 92% from 3 to 4 
weeks of age (p<.01) (Figure 3.3A), but then decreased by 39% (p<.05) from 4 to 5 
weeks of age (Figure 3.3A).  Adult-like levels of Ucp1 were achieved by 6-7 weeks, after 
which they were stably maintained.  In contrast to our findings at the transcript level, we 
found no change in BAT UCP1 protein levels from 3 to 4 weeks of age in control mice.  
We observed a 123% increase in BAT UCP1 at 5 weeks of age compared to 3 weeks of 
age (p<.01) (Figure 3.3B), which was followed by 45.5% decrease from 5 to 6 weeks 
(p=.06). Stable levels of UCP1 protein were then maintained through 13 weeks (Figure 
3.3B).   
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We next determined whether the peak of BAT UCP1 protein expression at 5 weeks is 
associated with changes in the expression of panel of genes linked to mitochondrial 
capacity and biogenesis (Mfn2, Mics1, Opa1, Tfam, Prohibitin) and oxidative 
phosphorylation/thermogenic activity (Ucp1, Dio2, Errα, Pgc1β, CoxIV, Cytochrome c).  
Most gene expression profiles did not track with the pattern of UCP1 (Supplemental 
Figure 3.1), but those that did were associated with mitochondrial structure.  We found 
mitofusin2 (Mfn2) (34) was increased by 103% at 4 weeks of age compared to 3 weeks of 
age (p=.088) and increased by 113% from 3 to 5 weeks of age (p<.05) (Figure 3.3C).  
Mics1 (35) expression increased from 4 to 5 weeks of age (52%, p<.05), achieving adult-
like levels by 7 weeks of age (38% increase from 5 to 7 weeks of age, p=.05) (Figure 
3.3D).  Although there was no significant change in carnitine palmitoyltransferase 1b 
(Cpt1b) from 3 to 5 weeks of age (21.2%, NS) (Supplemental Figure 3.1D), there was a 
significant (65%) increase in Cpt1b from 4 to 7 weeks of age (p=.01) (Supplemental 
Figure 3.1D).  Additionally, CoxIV gradually increased from 3 to 6 weeks of age (32.3%, 
p=.02) (Supplemental Figure 3.1E).   
 
Efforts to identify circulating BAT activators in the post-weaning period 
In effort to determine what is responsible for increased UCP1 protein at 5 weeks of age, 
we measured levels of several BAT-activating factors in the serum across the post-
weaning period.   
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1) Thyroid hormone 
We found that serum levels of free triiodothyronine (fT3) were similar in control mice at 
5 weeks of age compared to older ages (Supplemental Figure 3.2A).  Additionally, BAT 
Dio2 (responsible for the conversion of thyroxine (T4) to T3) was expressed in inverse 




While serum IGF-1 is elevated at the same time of the peak in BAT activity in humans 
(3, 24), we did not observe a peak in serum IGF-1 in males (Figure 3.4B) or females 
(Supplemental Figure 3.3A).  Serum IGF-1 levels were not associated with growth, as 
body weight and length were stable from 5 weeks of age (Figure 3.4C,D).  We found that 
liver Igf-1 mRNA expression, the primary source of serum IGF-1 (36, 37), was not 
increased at 5 weeks compared to later ages (Figure 3.4A).  Bone marrow Igf-1, another 
source of serum IGF-1, and BAT Igf-1 receptor (Igf1-R) were also not changed across the 
post-weaning period (Figure 3.4E,F).   
 
Autocrine IGF-1 signaling plays an important role in BAT development during gestation 
(38).  Therefore, we examined whether BAT-derived IGF-1 might also influence 
developmental processes in the post-weaning period.  We found that Igf-1 levels were 
slightly increased from 2 to 3 weeks of age, during the period of BAT expansion (Figure 
3.5).  BAT Igf-1 levels were further increased between 3-5 weeks of age (when BAT 
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weight is relatively stable), directly preceding the age of peak BAT UCP1 (Figure 3.3, 
3.5).  After 5 weeks of age, there was a dramatic decline in Igf-1 levels (43.7% reduction 
in Igf-1 from 4 to 6 weeks of age, (p=.018)) (Figure 3.5).  
 
A developmental delay of BAT capacity in the KO-AL mice 
The development of thermogenic circuits is delayed in KO mice fed an ad libitum diet 
(KO-AL), as they are cold intolerant until 6 weeks of age (39).  We next examined 
whether processes regulating the increase in mitochondrial capacity and function in the 
post-weaning period, hereafter referred to as “mitochondrial consolidation”, are impaired 
in KO-AL mice.  The sharp increase in UCP1 protein from 3 to 5 weeks of age was not 
seen in KO-AL mice (Figure 3.6A) (ANOVA NS).   
 
We also compared the expression profiles of several BAT mitochondrial genes in KO-AL 
vs. lean controls at 5 week of age.  Ucp1 expression was decreased in KO-ALs by 52% 
(p<.05) (Figure 3.6B), while UCP1 protein was decreased by 41% (NS) (Figure 3.6A).  
KO-AL mice also exhibited reduced BAT Pgc1β (41.3%, p=.07), Errα (50.2%, p<.01), 
Mics1 (55%, p<.01), Tfam (35.5%, NS), Mfn2 (34.2%, NS) and Opa1 (42.2%, p=.05) 
expression at 5 weeks of age compared to controls (Figure 3.6C).    
 
Expression of Igf-1 in BAT was reduced by 61.4% of KO-AL mice vs. controls at 5 
weeks (NS) (Figure 3.6D).  This difference was diminished by 9 weeks of age (Figure 
3.6E), and by 13 weeks, there was a trend toward increased BAT Igf-1 in KO-ALs 
compared to control mice (NS) (Figure 3.6F). 
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Evidence that paired-feeding restores developmental processes regulating BAT 
function 
We previously reported that paired-feeding of KOs from 3-10 weeks (KO-PF) leads to 
increased BAT capacity and activity at 10 weeks (2).  We next asked whether we could 
detect this change as early as 5 weeks, during the peak of UCP1 expression seen in lean 
controls.  Similar to what has been shown previously, there was a discrepancy between 
expression and protein levels of UCP1.  We found that UCP1 protein was expressed at 
higher levels in KO-PFs vs. KO-ALs at 5 weeks of age, but this was not reflected in 
Ucp1 transcript levels (Figure 3.7A,C,).  As we reported previously (2), KO-PF mice 
exhibited increased Ucp1 gene and protein expression levels at 13 weeks of age 
compared to KO-ALs (Figure 3.7B,C).   
 
We also evaluated Igf-1 expression in BAT and IGF-1 protein in the serum.  Igf-1 
expression was not increased in KO-PFs at 5 or 13 weeks of age compared to KO-ALs 
(Figure 3.7D,E).  Serum IGF-1 in KO-AL mice followed a similar pattern as in controls, 
but was blunted in the KO-PFs (Supplemental Figure 3.3B), consistent with their pattern 
of reduced growth rate at this time (Figure 2.5C)(2).   
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DISCUSSION 
Our previous research implicated 3-5 weeks of age as a period when caloric restriction 
could lead to lasting increases in BAT activity and reduced adiposity.  In this study, we 
characterized changes in markers of BAT capacity and activity across the peri-weaning 
period.  We next explored whether influences on these processes might underlie the 
metabolic improvements associated with early intervention.  We found that 2 to 3 weeks 
of age was a time of BAT expansion, coinciding with reduced thermogenic capacity in 
control mice.  We identified an increase in BAT Igf1 from 3 to 4 weeks of age, after 
which levels declined.  This increase was followed by a peak in thermogenic gene 
expression at 5 weeks of age in control mice, supporting a role for Igf1 in BAT 
mitochondrial “consolidation” at this time.  The peak of thermogenic gene expression 
was blunted at 5 weeks of age in KO-AL compared to controls, and subsequently rescued 
by paired-feeding. 
 
BAT undergoes rapid expansion within the first weak after weaning 
Within a week after birth in rodents, mitochondrial cristae are tightly packed and BAT 
capacity is maximal (26, 27).  Therefore, most studies of BAT development do not 
extend past 2 weeks of age. We found that cristae in lean mice lose this tight organization 
at 3 weeks of age (Figure 3.1B-F), making their mitochondrial structure comparable to 
that of KO mice at 3 weeks (Supplemental Figure 3.4).  Cristae disorganization was 
accompanied by reduced expression of BAT Ucp1, Dio2 and CoxIV from 2 to 3 weeks of 
age (Figure 3.1A).  These findings are consistent with reports that respiratory activity and 
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volume of the inner mitochondrial membrane is reduced in the period preceding weaning 
in rats (21, 22).   
 
We found that the period of reduced thermogenic gene expression in BAT coincided with 
a doubling of BAT weight (Figure 3.2A), raising the possibility that they are 
mechanistically linked.  The process underlying the increase in BAT weight has not yet 
been elucidated.  In theory, BAT expansion might reflect proliferation; if so, newly-born  
immature cells would not be expected to have tightly packed cristae.  Alternatively, 
increased BAT weight could also be explained by increased cell size due to the 
accumulation of larger lipid droplets, which could also interfere with mitochondrial 
capacity.  Further work is needed to elucidate this process.  
 
The role of IGF-1 signaling in BAT development and function 
We found an increase in the expression of thermogenic genes from 3 to 5 weeks of age 
(Figure 3.3).  These changes were preceded by increased BAT Igf-1 expression from 2 to 
4 weeks of age (Figure 3.5), consistent with the idea that Igf-1 plays a role in the 
maturation of BAT at this time.  IGF-1 has thermogenic effects on brown adipocytes 
(27), and promotes differentiation of brown adipocytes during fetal development (25, 26).  
Therefore, several groups have used Cre/lox approaches to study the role of IGF-1 
signaling in adipose tissue development and function.  Mice lacking either IGF-1R or 
IGF-1 in adipose tissue (using the Ap2-Cre driver) exhibit normal BAT weights (40, 41), 
suggesting that either IGF-1 or IGF-1R is not necessary for BAT development.  Mice 
lacking adipose tissue derived IGF-1R exhibit increased body weight by 10 weeks of age 
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(41), supporting the role of BAT IGF-1 signaling in energy homeostasis.  Recently, IGF-
1R has been knocked out specifically in the BAT, using the Ucp1-Cre driver (42).  This 
mouse model does not differ in body weight, yet has reduced cold tolerance (42).  It is 
possible that compensatory increases in the expression of insulin receptor (IR) (38, 43) is 
responsible for diminished body weight phenotypes in IGF-1R KOs.  In support of this 
idea, eliminating the redundancy in the system (IR/IGF-1R double knock out in adipose 
tissue) leads to 80% reductions in BAT weight and cold intolerance (38).  In summary, 
while IGF-1 signaling likely plays an important role in BAT development, it is difficult 
to study because of compensation in the system.  
 
Evidence for a peak of BAT activity at 5 weeks of age  
The increase in mitochondrial gene expression at 4-5 weeks of age supports the idea that 
there might be a peak of BAT thermogenic function in the peri-pubertal period, similar to 
what is found in humans (3).  We found that the increase in UCP1 protein content at 5 
weeks was not reflected in Ucp1 mRNA expression (Figure 3.3A,B).  This phenomenon 
is well documented in the literature (44, 45).  For example, while Xue et al. (2007) 
reported that BAT Ucp1 mRNA expression is maximal at P1, the peak of UCP1 protein is 
not observed until P10 (44).  These inconsistencies may stem from differences in the 
stability of UCP1 mRNA and protein under different environmental conditions.  The 
half-life (t1/2) of Ucp1 transcript is 8-10 hours (46, 47).  Not only is the UCP1 protein 
more stable than the transcript at baseline (t1/2 20 hours), but this stability is further 
enhanced in the stimulated state (t1/2 70 hours) (48).  We hypothesize that increased BAT 
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UCP1 from at 5 weeks of age reflects a time window when BAT capacity and activity are 
restored, following the transient decrease between 2-3 weeks.  
 
Expression of genes related to mitochondrial structure in the post-weaning period  
Of the 13 genes analyzed in BAT, we found that the gene that best correlated with the 
changes in UCP1 protein in the peri-weaning period was Mfn2.  MFN2 is a mitochondrial 
fusion protein, and its induction in BAT and skeletal muscle correlates with increased EE 
(34).  Conversely, its expression is reduced in obese animals (49).  First, we found Mfn2 
to be slightly decreased at 2 weeks compared to 3 weeks of age (Supplemental Figure 
3.5) (NS), coinciding with the disruption we found in mitochondrial structure at this time 
(Figure 3.1B).  An important issue to be addressed in the future is the structure of 
mitochondria at 2 weeks of age, to confirm that cristae disorganization is occurring at 3 
weeks of age, as opposed to a delay in the maturation of cristae in mice relative to rats.   
 
We found that Mfn2 was increased between 4-5 weeks of age compared to 3 weeks of age 
(Figure 3.3C), supporting the idea that it plays a role in the activation of BAT during this 
time period.  In vitro, Mfn2 is regulated by estrogen related receptor α (Errα) (34); 
however, we do not see any changes in Errα expression across the post-weaning period 
(Supplemental Figure 3.1).  Although Errα is necessary for the thermogenic response of 
BAT to cold (50), it is not yet clear whether Errα is necessary for the maturation of BAT.  
Errα KO mice exhibit normal EE (51) and cold-stimulated upregulation of thermogenic 
gene expression in BAT, although some Errα KO mice display cold intolerance in 
response to a 3 day cold challenge (34, 50).  This could be an artifact of reduced 
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mitochondrial abundance, as the mitochondrial cristae organization pattern was 
unchanged (50).  Mfn2 has been shown to be regulated by peroxisome proliferator-
activated receptor gamma coactivator 1 alpha (Pgc1α) (34), and therefore it would be 
interesting to look at Pgc1α gene expression during this time period. 
 
The upregulation seen in Mics1 is important, as Mics1 has a known regulatory role in 
mitochondrial cristae organization (35), and knock-down of Mics1 leads to disruption of 
cristae formation (35).  Furthermore, although both genes regulate cristae organization, 
Mics1 and Opa1 are distinct and do not seem to influence one another (35).  Therefore, 
our data support a role for Mics1, not Opa1, as the mediator of cristae formation during 
this time period. 
 
Thermogenic circuitry in KO mice is developmentally delayed  
We hypothesized that the peak of BAT UCP1 in the peri-weaning period would be 
disrupted in the obese KO-AL model.  Consistent with our hypothesis, KO-AL mice do 
not exhibit an increase in BAT Ucp1 mRNA or protein levels, nor Igf-1 levels across time 
points (Figure 3.6).  In fact, BAT Igf-1 and Ucp1 levels were reduced at 5 weeks in KO-
AL mice compared to controls (Figure 3.6A,B,D).  At 7 and 9 weeks of age, after the end 
of the peak in control mice, KO-AL and control mice have similar gene expression levels 
(Figure 3.6A,B,E), supporting the idea that KO-AL mice never developed a peak in BAT 
expression levels.  Similarly, mitochondrial genes that were increased between 3-5 weeks 
of age in control mice (Ucp1, Mfn2, Mics1, Igf1) were reduced in KO-AL mice at 5 
weeks of age (Figure 3.6B,C).  The reduction of Mics1 in KO-AL vs. control mice is 
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consistent with the observation that KO mice have disorganized cristae (as seen at 10 
weeks of age) (Figure 2.6B)(2).  These data support the hypothesis that the reduced BAT 
activity in KO-AL mice stems from a failure to “reconsolidate” BAT mitochondrial 
structure after weaning.  
 
Impact of paired-feeding on BAT maturation in the post-weaning period 
We previously showed that KO-PF mice have increased EE compared to KO-AL mice 
(Figure 2.3A, 2.4A) (2).  Therefore, we hypothesized that paired-feeding might rescue the 
processes driving the “reconsolidation” of BAT mitochondrial cristae and the increase in 
BAT capacity and activity in the peri-weaning period.  In support of this idea, we found 
that paired-feeding resulted in increased UCP1 protein levels at 5 weeks of age (Figure 
3.7C).  An important caveat is that we only had n=2 mice for the KO-AL in this cohort to 
compare with KO-PF mice, and therefore this experiment must be repeated.  
Furthermore, KO-AL mice are developmentally delayed, so it is important to carry out 
studies to map the maximal time point (if any) at which UCP1 might be elevated in BAT 
to fully determine whether the peak is delayed or entirely absent.   
 
In previous studies, we reported that KO-PF mice exhibited increased Ucp1 expression 
levels at 10 weeks of age (Figure 2.3D) (2).  Although we did not find Ucp1 mRNA to be 
increased at 5 weeks of age in the KO-PF mice, we found increased UCP1 protein levels 
when compared to KO-AL (Figure 3.7A,C).  It is possible that the failure to observe 
increased Ucp1 expression at 5 weeks in KO-PFs stems from differences in the prandial 
state when the mice were euthanized.  The published data were generated from mice in 
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the fasted state, while the new data were generated from mice in the fed state.  In our 
experience, increases in BAT Ucp1 expression in older KO-PFs vs. KO-ALs are not as 
significant in the fed state (13 weeks of age, Figure 3.7B), as compared to the fasted state 
(10 and 20 weeks of age, Figure 2.3D, 2.4D) (2).  These observations are consistent with 
the idea that the response to fasting is blunted in KO-PF mice relative to AL-KO mice.  
This issue will be discussed further in Chapter 4. 
 
Part II:  Outstanding Issues  
The main weakness of this study is that UCP1 is the sole readout of BAT activity.  We 
first explored whether we could use longitudinal measurements of EE in the Columbus 
Instruments Comprehensive Lab Animal Monitoring System (CLAMS) Oxymax 
metabolic cages to detect increased BAT activity in the post-weaning period.  We 
initially tried to derive a multiple regression metabolic equation suitable for each age (in 
weekly increments).  Because absolute and relative amounts of lean and fat mass were 
changing on a daily basis during this period, we were not able to develop a method to 
make meaningful statements about EE.  In theory, comparisons of energy consumed 
versus energy expended, as well as total VO2 could be used to determine how fuel 
utilization changes over time within an individual animal.  Going forward, functional 
BAT activity assays, such as glucose uptake studies, could be used to determine whether 
the increased BAT UCP1 correlates to metabolic activity of the BAT.   
 
Please refer to Chapter 4 for the future directions of this project. 
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Part III:  Future Outlook 
In this study, we discovered that BAT capacity and activity are very dynamic in the peri-
weaning period; a marked decline in these parameters between 2-3 weeks of age is 
followed by improvements in the post-weaning period.  The decrease in BAT capacity 
occurs during a time when the mass of the BAT depot doubles.  Due to the compression 
of rodent development, it is difficult to translate the events under investigation here into 
humans.  There are two ages when BAT expansion has been reported in humans: infancy 
and puberty (4, 9, 12).  If expansion is also followed by reductions in BAT capacity (i.e., 
due to the presence of immature mitochondria in newly-born cells), it is possible that the 
subsequent “consolidation” of mitochondrial structure could contribute to high levels of 
BAT activity reported in infants and teens (4, 9, 12).  As this process is impaired by 
obesity and rescued by weight loss, we hypothesize that the process of “consolidation” 
might represent a novel target for interventions in obese children.  The identification of 
biomarkers for this process is critical to test this idea in humans. 
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FIGURES 
 
Figure 3.1.  2 to 3 weeks is a time of reduced BAT capacity in control mice.  (A) 
Gene expression levels from 2 vs. 3 weeks of age.  (B) 3 week BAT mitochondria.  (C) 
10 week BAT mitochondria. (D) Total number of cristae per mitochondrion, (E) percent 
normal cristae per mitochondrion, and (F) percent abnormal cristae/mitochondrion in 3 
vs. 10 weeks of age.  Error bars represent standard error of mean.  Significance was 
determined between groups by Student’s or Welch’s t-test accordingly.  For (E) and (F), 
data underwent arcsin transformation prior to statistical analysis.  Data for gene 
expression was generated from 2wk; n=4, 4wk; n=5.  Mitochondrial analysis was 
generated from 3wk; n=2, 10wk; n=4.  
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Figure 3.2.  BAT expansion occurs from 2 to 3 weeks of age in control mice.  (A) 
BAT weight from 2 to 3 weeks of age.  (B) BAT, (C) liver, (D) iFat, and (E) gFat weights 
over time.  Significance in (A) was determined between groups by Student’s or Welch’s 
t-test accordingly.  Significance in (B-E) was determined between groups using one-way 
ANOVA and Student’s or Welch’s t-test accordingly.  (A) * represents <.05.  (B) * 
represents statistical difference (<.05) from all other groups.  (C-E) Different letters 
(a,b,c) represent statistical significance.  Data generated from (A) n=4-5 in each group, 
(B-E) n=2-7 within each group. 
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Figure 3.3.  Peak in BAT thermogenic and mitochondrial genes at 5 weeks of age in 
control mice.  (A) BAT Ucp1 gene expression and (B) UCP1 protein over time.  (C) 
Mfn2 and (D) Mics1 gene expression in BAT over time.  Significance was determined 
between groups using one-way ANOVA and Student’s or Welch’s t-test accordingly.  
Different letters (a,b,c) represent statistical significance.  Data generated from n=4-7 
within each group. 
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Figure 3.4.  Serum IGF-1 does not track with growth rate.  (A) Liver Igf-1 and (B) 
serum IGF-1 levels.  (C) Body weight gain.  (D) Naso-anal length across ages.  (E) Bone 
marrow Igf-1.  (F) BAT Igf-1R expression levels.  Significance was determined between 
groups using one-way ANOVA and Student’s or Welch’s t-test accordingly.  Different 
letters (a,b,c) represent statistical significance.  Data generated from n=2-9 within each 
group.  Liver expression data (A) generated from n=1-5. 
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Figure 3.5. BAT Igf-1 is upregulated between 2-5 weeks of age in control mice.  
Significance was determined between groups using one-way ANOVA and Student’s or 
Welch’s t-test accordingly.  Different letters (a,b,c) represent statistical significance.  
Data generated from n=3-7 in each age group. 
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Figure 3.6.  KO-AL mice do not exhibit a peak in BAT thermogenic function.   
(A) BAT UCP1 protein levels at 3, 5, 7, and 13 weeks of age in control vs. KO mice.  (B) 
BAT Ucp1 gene expression levels at 5, 9 and 13 weeks of age between control vs. KO 
mice.  (C) Mitochondrial gene expression analysis in control vs. KO mice.  Igf-1 gene 
expression in control vs. KO mice at (D) 5, (E) 9, and (F) 13 weeks of age.  Black bars 
represent control mice, blue bars represent KO mice.  Error bars represent standard error 
of the mean.  Significance was determined between groups by Student’s or Welch’s t-test 
accordingly. * represents p<.05.  Data generated from controls; n=2-7, KO-AL; n=2-5. 
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Figure 3.7. Paired-feeding rescues thermogenic activation in BAT at 5 weeks of age.  
(A) BAT Ucp1 gene expression at 5 weeks of age.  (B) BAT UCP1 protein levels at 5 
and 13 weeks of age.  BAT Igf-1 gene expression at (C) 5 weeks and (D) 13 weeks of age 
in KO-AL vs. KO-PF mice.  Blue bars represent KO-AL mice, red bars represent KO-PF 
mice.  Error bars represent standard error of mean.  There was no significance between 
groups, as determined by Student’s or Welch’s t-test.  Data generated from AL; n=2-3, 
PF; n=3-6. 
  
	   126	  
SUPPLEMENTAL FIGURES 
 
Supplemental Figure 3.1.  Unchanged mitochondrial related genes across different 
ages in control mice.  BAT (A) Errα, (B) Tfam, (C) Pgc1β, (D) Cpt1b, (E) CoxIV, (F) 
Opa1, (G) Cytc, (H) prohibitin across the peri-weaning period.  Error bars represent 
standard error of mean.  Significance was determined between groups using one-way 
ANOVA and Student’s or Welch’s t-test accordingly.  Arbitrary units represent relative 
expression compared to b-actin.  Different letters (a,b,c) represent statistical significance.  
Data generated from n=2-7 mice in each group. 
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Supplemental Figure 3.2.  Serum T3 and BAT deiodinase 2 expression levels are 
unchanged during the early peri-weaning period.  (A) Serum T3 and (B) BAT Dio2 
expression levels through the peri-weaning period.  Error bars represent standard error of 
the mean.  There was no significance between groups, as determined by Student’s or 
Welch’s t-test accordingly.  Data generated from n=3-8 in each group. 
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Supplemental Figure 3.3.  Serum IGF-1 follows a similar pattern in female wild type 
and male AL-KO mice, but is blunted in KO-PF during the peri-weaning period.  
(A) Female serum IGF-1 levels.  (B) Male KO-AL and KO-PF serum IGF-1 levels.  
Significance was determined between groups using one-way ANOVA and Student’s or 
Welch’s t-test accordingly.  Different letters represent statistical significance.  * 
represents p<.05 between KO-AL and KO-PF.  (A) Data generated from n=2-8 in each 
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Supplemental Figure 3.4.  3 week control and KO mice have similar mitochondrial 
structure.  Electron micrograph of (A) control and (B) KO mice at 3 weeks of age.  (C) 
Total number of cristae per mitochondrion.  (D) Percent normal cristae per 
mitochondrion.  (E) Percent abnormal cristae per mitochondrion.  Scale bar represents 
500nm.  Error bars represent standard error of mean.  No significance difference was 
found for (C) using Student’s t-test.  For (D) and (E), data underwent arcsin 
transformation prior to statistical analysis, no statistical significance was found.  Data 
generated from control; n=2, KO; n=4. 
  




Supplemental Figure 3.5.  Reduced BAT Mfn2 expression from 2 to 3 weeks of age.  
Black bar represents 2 weeks of age, white bar represents 3 weeks of age.  Error bars 
represent standard error of mean.  No statistical significance was found using Student’s t-
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Chapter 4: Concluding Remarks and Future Directions 
Part I: Generalizability of lessons learned from rodent models of early 
intervention 
While there are many established mouse models of diet- and genetic-induced obesity, 
increased adiposity is rarely seen early enough to be useful in studies of early 
intervention  (see Chapter 1 for full review).   Db/db and ob/ob mice exhibit early-onset 
hyperphagia and obesity, but they do not respond normally to caloric restriction (CR), 
because they preferentially maintain fat mass vs. lean mass (1-5).  As described in 
Chapter 2, we used the Nkx2.1-Cre;Leprflox/flox mice (KO) to study whether early 
intervention could produce lasting improvements in obesity-related outcomes.  We found 
that paired-feeding KO mice from 3-10 weeks of age (KO-PF) results in persistent 
reductions in adiposity, likely due to enhanced capacity and activity in brown adipose 
tissue (BAT) (Chapter 2)(6).  Comparisons between our findings and two other models of 
early intervention will be discussed below. 
 
Otsuka Long-Evans Tokushima Fatty rats (OLETF) exhibit early-onset hyperphagia and 
obesity due to a deficit in CCK receptor signaling (7).  These studies demonstrated 
differences between males and females; caloric restriction from 3-6 weeks of age 
produced lasting reductions in obesity in males only (7, 8).  Although the effect on males 
was attributed to decreased food intake, endpoints related to energy expenditure were not 
assessed.  This is in contrast to our KO model, which has the same response to early 
paired-feeding regardless of gender (Chapter 2)(6).  However, we cannot exclude the 
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possibility that CR in the OLETF rat model would also produce lasting effects in females 
if the intervention was extended to 10 weeks, as we had done in our model.   
 
Mice lacking POMC in the arcuate nucleus of the hypothalamus (arcPomc-/-) (with 
normal expression in the brainstem and pituitary) have been used to study early 
intervention (9).  Restoring Pomc expression at any age could correct the hyperphagia, 
yet the impact of restoring Pomc expression on body weight was dependent on the age at 
which the intervention was initiated.  Interventions beginning at postnatal day 25 (P25) 
could completely rescue the lean phenotype, while those initiated later were less 
effective, particularly in males (9).  These data support our hypothesis that baselines of 
energy expenditure are established in the peri-weaning period, likely between 4-6 weeks 
of age.  The major difference in the degree of body weight rescue in the arcPomc-/- mice 
and in our KO model is likely due to large differences in food intake in the two systems.   
 
Part II: Defining the developmental window to establish thermoregulatory 
circuits 
Concluding Remarks 
Obesity is associated with reductions in sympathetic tone onto the BAT (10, 11), 
resulting in abnormal BAT morphology and function (12-14).  Rearing in small litter 
size, a method of early overfeeding resulting in increased body weight later in life, results 
in mice with impairments in BAT morphology (i.e., larger lipid droplets (15)), activity 
(as evidenced by reduced BAT temperature (15)), and reduced capacity to respond to a 
cold challenge (16).  These impairments in BAT function are similar to what is seen in 
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ob/ob mice, which are cold intolerant unless slowly acclimated (13).  Taken together, 
these data support the role of BAT thermoregulation in the maintenance of body 
temperature, body weight and energy homeostasis, thus leading researchers to investigate 
how to harness BAT activation as a therapeutic target for the obesity epidemic.  
 
Similar to what is seen in the ob/ob mice, mitochondrial structure in KO mice is 
disorganized compared to control mice throughout all ages after weaning (as seen by 
increased number of abnormal cristae/mitochondrion) (Figure 2.6B,G)(6).  We found that 
the KO and control mice have similar mitochondrial structure at 3 weeks of age 
(Supplemental Figure 3.4), implicating the functional development of BAT after 3 weeks 
of age as an important indicator of later thermogenic capacity.  Importantly, the control 
mice can survive cold at 3 weeks of age regardless of the initial mitochondrial structure, 
while the KO mice cannot (17).  These observations support the idea that deficits in 
thermoregulatory circuits, rather than mitochondrial disorganization per se, is responsible 
for cold intolerance of KOs at 3 weeks.  At least some components of the 
thermoregulatory circuits eventually develop in KOs, as they can defend against a cold 
challenge at 6 weeks of age (17). 
 
Control mice exhibit a peak in the thermogenic protein (UCP1) at 5 weeks of age (Figure 
3.3B), whereas the KO mice do not (Figure 3.6A).  This phenomenon seems to be 
restored in the KO-PF mice (Figure 3.7C), leading to the hypothesis that paired-feeding 
increases BAT capacity to respond to endogenous signals driving thermogenic activity at 
5 weeks of age; this enhanced capacity persists even after release to ad libitum feeding.  
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How paired-feeding rescues the BAT thermoregulatory system remains unclear.  While 
the increase in Igf-1 expression in the peri-weaning period occurs at the right time to play 
a role in this process, the failure to see an upregulation in Igf-1 in KO-PF compared to 
KO-AL (Figure 3.7D,E) argues against the idea that this is the mechanism by which 
paired-feeding is working.  This is an important question of future research. 
 
Future Directions 
(i) Cold tolerance: To examine whether paired-feeding corrects the developmental delay 
in the thermogenic circuits of the KO mice, we must look at markers of thermoregulatory 
system at this time.  Previously, the Zeltser lab showed that the KO mice are able to 
defend body temperature in response to cold by 6 weeks of age.  It is important to note 
that it has been reported that 75 minutes (which was the duration of cold exposure at this 
time) is not long enough to mount a thermogenic response of BAT (18), therefore the 
ability to maintain body temperature at this time might rely on other mechanisms, such as 
shivering from skeletal muscle.  The s/s mouse model, which exhibits early-onset obesity 
as a result of impaired leptin-mediated signaling through the Stat3 pathway, (19), can 
tolerate 75 minutes of cold exposure better than the db/db mice, which has been 
attributed to their increased lean mass deposition (18).  If true, the response of our KO 
mouse to cold at 6 weeks is to be expected, as lean mass deposition is increased at this 
time (Figure 2.5C).  To test BAT functionality, cold exposure should be prolonged (i.e. 4-
12 hours).  The hypothesis that the KO-PF mice will develop the ability to tolerate cold 
more rapidly is supported by the studies in ob/ob mice.  Caloric restriction improves cold 
tolerance in obese mice at any age (20-22), which is likely attributed to improved BAT 
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thermogenic capacity in response to food restriction (6, 21, 22).  It will be interesting to 
determine whether KO-AL mice have impaired response to a longer cold challenge in 
adulthood, and whether paired-feeding corrects this deficit in adulthood, even after ad 
libitum feeding resumes.  This will parse out the effects of early paired-feeding on the 
later thermoregulatory system.  Additionally, it is well established that BAT deiodinase 2 
(Dio2) is necessary for maintenance of body temperature in response to cold (23), and 
KO-PF mice exhibit increased BAT Dio2 compared to KO-AL mice at 10 and 20 weeks 
of age (Figure 2.3D, 2.4D), further supporting the hypothesis that they should have 
improved response to cold throughout adulthood. 
 
(ii) Fasting-induced torpor: When food is unavailable, mice are known to go into a state 
of torpor, leading to dramatic reductions in core body temperature and metabolism (24).  
Our lab previously showed that the KO mice are more sensitive to fasting when singly 
housed, and are more likely to enter the torpor state initiated by an overnight fast 
compared to control mice (25), similar to what is seen in ob/ob mice (22).  We 
hypothesize that this phenomenon might be rescued in the KO-PF mice.  To test this, we 
can measure body temperature after an overnight fast in KO-PF versus KO-AL mice, to 
elucidate whether paired-feeding rescues these mice from dramatic reductions in body 
temperature in response to fasting.  This phenomenon is also seen in triiodothyronine 
(T3) levels, which are reduced in the fasting state in KO-AL compared to controls, yet 
the difference disappears in the fed state (Figure 4.1).  In the fed vs. fasted state, control 
mice exhibited a 38% reduction in serum free T3 levels (fT3) (p=.08), while KO-AL 
mice exhibited a 61.5% reduction in serum fT3 levels from the fed to fasted state (p<.05) 
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(Figure 4.1).  Additionally, KO-AL mice had 22% higher serum fT3 levels compared to 
control mice in the fed state, while they exhibited 25% lower serum fT3 in the fasted 
state when compared to controls.  This is further reminiscent of previous work done in 
ob/ob mice, which showed that reductions in fT3 in response to fasting are much greater 
in ob/ob compared to controls, even though the fed baseline levels of fT3 were the same 
between the two groups (22).  Therefore, KO mice seem to be more sensitive to 
nutritional perturbations in the system, and further work is needed to determine whether 
paired-feeding rescues this sensitivity.   
 
Part III: The role of IGF-1 in BAT development 
Concluding Remarks 
Insulin-like growth factor 1 (IGF-1) is important for BAT development, and adipose 
specific IGF1R/insulin receptor (IR) double knockout results in a smaller BAT depot 
(26).  Additionally, knocking out IGF-1R specifically in adipose tissue results in 
increased body weight gain at 10 weeks of age (27), consistent with an important role in 
BAT formation and/or function.  In our current study, we found that upregulation of BAT 
Igf-1 (Figure 3.5) preceded the increased UCP1 content at 5 weeks of age in control mice 
(Figure 3.3B).  Taken together, we hypothesize that Igf-1 plays a role in “consolidation” 
and restructuring of the BAT depot after tissue expansion, and this “consolidation” is 
necessary for increased thermogenic capacity of the BAT in the wild type system.  In 
support of this idea, there is evidence that Igf-1 plays a crucial role in mitochondrial 
stabilization in cardiomyocytes (28), although this has not been examined in BAT.   
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Future Directions 
(i) Mitochondrial structure: Originally, it was thought that BAT differentiation and 
thermogenic initiation was completed prior to weaning (29, 30).  We discovered that 
BAT expansion in the last week of weaning is associated with a precipitous decline in 
BAT capacity and thermogenic activity.  We do not yet know what is driving the 
expansion of the depot at this time, and we do not know whether this expansion is 
mechanistically linked to disorganized mitochondrial structure at 3 weeks.  First, it is 
important to confirm that cristae are tightly packed at 2 weeks in mice, because studies of 
mitochondrial structure in the neonatal period were performed in rats (31, 32).  Then, we 
must determine what is driving increased BAT mass between 2-3 weeks of age – 
proliferation and/or increased adipocyte size due to increased lipid accumulation.  
 
(ii) Mitochondrial consolidation and activation initiated by paired-feeding:  We do not yet 
know the time point at which tight packing of mitochondrial cristae is restored cristae, 
only that it happens before 10 weeks of age in control (and pair-fed) mice (Figure 
2.6A,C).  In this dissertation I reported that BAT Igf-1 expression is blunted in KO-AL 
mice compared to controls at 5 weeks of age (Figure 3.6D), consistent with the 
hypothesis that deficits in Igf-1-mediated BAT mitochondrial “consolidation” contribute 
to obesity in this model.  Paired-feeding does not enhance BAT Igf-1 at 5 weeks of age 
compared to KO-AL mice (Figure 3.7D).  These data suggest that paired-feeding does 
not correct for the blunted Igf-1 levels seen at 5 weeks of age in the KO mice.  Therefore, 
paired-feeding (which is known to correct for mitochondrial capacity (21)), might be 
acting on mitochondrial “consolidation” independent of the Igf-1 pathway.  Since paired-
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feeding results in increased fT3 levels (Figure 2.3C, 2.4C)(6), it is possible that fT3 is 
driving mitochondrial consolidation in the KO-PF mice.  Therefore, chronic treatment 
with fT3 during the paired-feeding period might result in improvements in mitochondrial 
packing. 
 
(iii) Mitochondrial structure vs. activation:  We hypothesize that the increased 
environmental stress due to single housing during paired-feeding enhances BAT capacity 
and activation during the critical time window.  To parse out the effects of paired-feeding 
vs. environmental stimuli on energy expenditure, rearing mice in thermoneutral 
conditions would mitigate the cold stress of the single-housing environment.  The 
thermoneutral environment negates the need for BAT, and therefore BAT is more 
unilocular, resembling WAT, and contains reduced UCP1 (33, 34).  Moreover, BAT 
mitochondrial cristae appear more disorganized under thermoneutral conditions (34). 
Paired-feeding might still result in improved mitochondrial structure at thermoneutrality, 
as paired-feeding can correct for cristae organization defects in the mitochondria (21), but 
mice would not be subject to constant activating signals (i.e. cold), thereby resulting in 
reduced basal metabolic rate (BMR) compared to those pair-fed at room temperature. 
 
Part IV: Concluding Remarks 
We and others have shown that caloric restriction and/or paired-feeding results in 
improvements of mitochondrial capacity (6, 21, 22).  Improvements in capacity alone, 
however, are not enough to elicit improvements in thermogenesis (35).  Because our mice 
are singly housed throughout the experimental paradigm, paired-feeding does not only 
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improve mitochondrial structure (capacity), but increases activation in response to 
environmental stress which might upregulate thermogenic genes during a critical time 
period.   
 
Current efforts in the lab have focused on discerning the relevance of BAT mitochondrial 
structure in humans.  As discussed at length throughout this dissertation, human BAT 
activity has been identified, and is inversely correlated with age (36-38) and BMI status 
(39, 40).  It has not yet been elucidated whether mitochondrial capacity is disrupted in 
BAT of obese individuals.  We have sought to address this question by acquiring fat 
samples from pediatric obesity patients (Appendix II).  Our current methods to acquire 
BAT and isolate mitochondria in these patients need to be refined.  Our research has the 
potential to identify mitochondrial disorganization in adolescents as a contributing factor 
to subsequent obesity status in humans.  Ideally, future research will be focused on 
acquiring BAT samples from individuals early in life, detecting whether mitochondrial 
structure is impaired, and using that information along with longitudinal analysis on 
weight status to determine whether mitochondrial structure preceding obesity could be 
used as a biomarker to determine future obesity risk. 
 
Elucidating the driving mechanism by which paired-feeding is increasing BMR in young 
obese rodents will be a valuable tool to provide insight into the treatment of pediatric 
obesity.  Even if the right age to intervene is identified, calorie restriction might not be 
enough to elicit long-term weight loss success.  The combination of the improved BAT 
capacity (upon caloric restriction) and activation (cold, adrenergic stimulation) might be 
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the key role to permanently enhance BMR.  This idea is supported by the studies 
suggesting that combination therapies (dieting plus physical activity) produce more 





Figure 4.1. Fasting elicits a greater decrease in serum T3 in KO-AL than control 
mice.  Black bars represent controls in the fed and fasted state, blue bars represent KO-
AL in the fed and fasted state.  Error bars represent standard error of the mean.  Statistical 
significance was determined by Student’s t-test.  * represents p<.05.  Data were generated 
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APPENDIX I: Organ Contribution to Increased Energy Expenditure in 
KO-PF Mice 
In effort to determine the mechanism by which energy expenditure is increased in pair-
fed (KO-PF) mice, we examined metabolically active tissue known to regulate energy 
expenditure.  We analyzed gene expression in pituitary, hypothalamus (Appendix Figure 
1.1, 1.2), white adipose tissue (Appendix Figure 1.3, 1.4, 1.5), skeletal muscle (Appendix 
Figure 1.6), liver (Appendix Figure 1.7, 1.8), brown adipose tissue (BAT) (Appendix 
Figure 1.9-1.13) and plasma catecholamine levels (Appendix Figure 1.14).  Based on our 
findings below, we were able to rule out contributions of other organs in modulating 
energy expenditure in the KO-PF mice at 10 and 20 weeks of age compared to KO-AL 
mice.  Ongoing studies are being carried out to determine the mechanism by which BAT 
is activated in KO-PF mice at a young age.  All mice were fasted overnight before 
sacrifice. 
  
	   151	  
Pituitary and hypothalamus 
One of the most striking phenotypes observed in KO-PF mice compared to the KO-AL 
mice was the elevated triiodothyronine (T3) level.  Because the hypothalamic-pituitary-
thyroid axis (HPT) is an important regulator of thyroid levels, we looked at whether the 
HPT axis was more active in the KO-PF mice.  We did not find evidence that any 
changes in the HPT axis occurred during paired-feeding (Appendix Figure 1.1, 1.2), 
therefore ruling out HPT regulation of the elevated T3 levels. 
Appendix Figure 1.1. Pituitary Dio2 and TSHb do not differ between PF and AL 
mice at 10 and 20 weeks of age.  (A) Pituitary Dio2 at 10 weeks (AL; n=5, PF; n=7) and 
(B) 20 weeks (AL; n=6, PF; n=9).  (C) Pituitary TSHb at 10 weeks (AL; n=5, PF; n=7) 
and (D) 20 weeks (AL; n=3, PF; n=8).  No statistical significance was found using 
Student’s and Welch’s T-test accordingly.  Abbreviations: Dio1; Deiodinase 1.  TSHb; 
Thyroid stimulating hormone β. Arbitrary units: relative expression to β-actin. 
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Appendix Figure 1.2. Hypothalamus gene expression at 10 and 20 week of age 
between paired-feeding and ad libitum KO does not differ.  (A) Dio2 at 10 weeks 
(AL; n=5, PF; n=7) and (B) 20 weeks (AL; n=5, PF; n=3).  (C) Dio3 at 10 weeks (AL; 
n=5, PF; n=7) and (D) 20 weeks (AL; n=5, PF; n=3).  (E) TSH-b at 10 weeks (AL; n=5, 
PF; n=5) and (F) at 20 weeks (AL; n=5, PF; n=3).  (G) TTR at 10 weeks (AL; n=5, PF; 
n=7) and (H) 20 weeks (AL; n=5, PF; n=3).  Abbreviations:  Dio2; Deiodinase 2.  Dio3; 
Deiodinase 3.  TSHb; Thyroid stimulating hormone-β.  TTR; Transthyretin.  Arbitrary 
units: relative expression to β-actin. 
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White adipose tissue 
To determine whether browning of inguinal and gonadal brown adipose tissue influenced 
energy expenditure in the KO-PF mice, we examined white adipose tissue (WAT) depots 
of uncoupling protein 1 (Ucp1) expression.  It was necessary to dilute cDNA to a 1/5 
dilution in order to detect any Ucp1, and there was no detectable difference between the 
KO-PF and KO-AL at either 10 or 20 weeks of age in inguinal adipose tissue (iFat) 
(Appendix Figure 1.3 A,B) or gonadal adipose tissue (gFat) (Appendix figure 1.4 A,B).  
Additionally there was no change in β3-adrenergic receptor (β3-AR) in iFat (Appendix 
Figure 1.3 C,D) and gFat (Appendix Figure 1.4 C,D), further supporting the hypothesis 
that browning of WAT is not driving the metabolic phenotype in these mice.  
Additionally, we looked at Hormone sensitive lipase (Hsl) in WAT, which was not 
changed (Appendix figure 1.5). 
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Appendix Figure 1.3. Increased energy expenditure is not due to browning of 
inguinal fat.  (A) Ucp1 at 10 weeks (CON; n=5, AL; n=4, PF; n=4) and (B) 20 weeks 
(CON; n=5, AL; n=5, PF; n=7).  (C) β3AR at 10 weeks (CON; n=5, AL; n=4, PF; n=5) 
and (D) 20 weeks (CON; n=4, AL; n=5, PF; n=7).  Significance was determined using 
one way ANOVA followed by post-hoc LSD.  Student’s or Welch’s T-test was 
performed accordingly.  Abbreviations: Ucp1; Uncoupling protein 1. β3-AR; β-3 
adrenergic receptor.  Arbitrary units: relative expression to β-actin. 
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Appendix Figure 1.4.  Increased energy expenditure is not due to browning of 
gonadal fat.  (A) Ucp1 at 10 weeks (CON; n=5, AL; n=2, PF; n=6) and (B) 20 weeks 
(CON; n=3, AL; n=3, PF; n=5).  (C) b3AR at 10 weeks (CON; n=5, AL; n=2, PF; n=5) 
and (D) 20 weeks (CON; n=4, AL; n=5, PF; n=7).  Significance was determined using 
one way ANOVA followed by post-hoc LSD.  Student’s or Welch’s T-test was 
performed accordingly.  Abbreviations: Ucp1; Uncoupling protein 1. β3AR; β-3 
adrenergic receptor.  Arbitrary units: relative expression to β-actin. 
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Appendix Figure 1.5.  Hsl is WAT is not changed by paired-feeding.  (A) Ifat Hsl at 
10 weeks (CON; n=5, AL; n=4, PF; n=5) and (B) 20 weeks (CON; n=3, AL; n=5, PF; 
n=8).  (C) Gfat Hsl at 20 weeks (CON; n=4, AL; n=6, PF; n=7).  Significance was 
determined using one way ANOVA followed by post-hoc LSD.  Student’s or Welch’s t-
test was performed accordingly.  Abbreviations: Hsl; hormone sensitive lipase.  Arbitrary 
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Skeletal Muscle 
To determine the contribution of skeletal muscle uncoupling protein in the energy 
expenditure phenotype in KO-PF mice at 10 weeks of age, we looked at uncoupling 
protein 3 (Ucp3) gene expression.  We did not see increased Ucp3 in skeletal muscle at 
10 weeks of age in the KO-PF mice compared to the KO-AL mice (Appendix Figure 
1.6).  We found Ucp3 in the skeletal muscle to be reduced in KO-PF at 10 weeks of age 
compared to KO-AL (Appendix Figure 1.6).  This dramatic decrease might be a 
compensatory mechanism of the skeletal muscle due to the increased BAT 
thermogenesis. 
Appendix Figure 1.6.  Skeletal muscle Ucp3 (Uncoupling protein 3) does not 
contribute to increased energy expenditure in KO-PF mice at 10 weeks of age.  (KO-
AL; n=5, KO-PF; n=5).  Significance was determined using Student’s t-test.  Arbitrary 
units: relative expression to β-actin. 
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Liver 
To try and determine the mechanism by which energy expenditure is increased, we 
looked at several genes implicated in transcription of BAT activators as well as the bile 
acid pathway.  Deiodinase 1 (Dio1) mRNA levels, the primary deiodinase in the liver to 
convert thyroxine (T4) to triiodothyronine (T3).  Dio1 was not changed between groups 
(Appendix Figure 1.7A,B).  Fibroblast growth factor-21 (Fgf21) was unchanged in liver 
of KO-PF versus KO-AL mice (Appendix Figure 8C,D).  Additionally, insulin-like 
growth factor binding protein (Igfbp) was unchanged (Appendix Figure 1.7E,F).  Bile 
acids are known to influence BAT activity via its receptor (TGR5), and bile acid 
supplementation has been shown to dampen weight gain on a high fat diet (1).  We 
therefore looked at the bile acid conversion pathway (Cytochrome p450s (CYPs)).  The 
bile acid pathway was unchanged in these mice (Appendix Figure 1.8) with the exception 
of liver Cyp7a1, the rate limiting step in bile acid synthesis.  Cyp7a1 was upregulated in 
KO-PF mice at 20 weeks only (Appendix Figure 1.8), which could contribute to the 
sustained energy expenditure phenotype in the KO-PF mice.  Overall, liver gene 
expression was unchanged by paired-feeding (Appendix Figure 1.7,1.8). 
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Appendix Figure 1.7.  Liver gene expression. (A) Liver Dio1 at 10 weeks (AL; n=4, 
PF; n=5) and 20 weeks (B) (AL; n=5, PF; n=9).  (C) Liver Igf1 at 10 weeks (AL; n=4, 
PF; n=6) and (D) 20 weeks (AL; n=6, PF; n=8).  (E) Liver Igfbp at 10 weeks (AL; n=4, 
PF; n=6) and (F) 20 weeks (AL; n=6, PF; n=8).  Error bars represent standard error of 
mean.  Blue bars represent KO-AL, red bars represent KO-PF.  No significance was 
found between groups by Student’s or Welch’s t-test accordingly.  Abbreviations: Dio1; 
Deiodinase 1.  Fgf21; Fibroblast growth factor 21.  Igf1bp; Insulin-like growth factor 1 
binding protein.  Arbitrary units: relative expression to β-actin. 
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Appendix Figure 1.8. Bile acid conversion pathway.  (A) Liver Cyp8b1, Cyp7A1, 
Cyp2b10, Cyp2d9 mRNA levels at 10 weeks (AL; n=4, PF; n=6). (B) Liver Cyp8b1, 
Cyp7A1, Cyp2b10, Cyp2d9 mRNA levels at 20 weeks (B) (AL; n=6, PF; n=8).  Error 
bars represent standard error of mean.  Blue bars represent KO-AL, red bars represent 
KO-PF.  Significance was found between groups by Student’s or Welch’s t-test 
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Brown adipose tissue 
We looked at BAT FGF-21 signaling to rule out FGF-21 as a potential candidate for 
increasing energy expenditure in the KO-PF mice.  BAT Fgf21 was not increased in KO-
PF mice at 10 or 20 weeks of age (Appendix Figure 1.9A,B).  Additionally, FGF21 
receptor duplex (β-klotho and FgfR1) was unchanged in KO-PF mice at 10 or 20 weeks 
of age (Appendix Figure 1.9A,B).   
 
Because one of the major phenotypes in our model is increased energy expenditure, we 
looked at the adrenergic receptors in the brown adipose tissue to determine whether there 
were differences induced by paired-feeding.  We found no differences in adrenergic 
receptor levels in KO-PF versus KO-AL mice at 10 and 20 weeks of age (Figure 1.10).  
Additionally, we decided to look at other BAT activators, such as the receptor to bone 
morphogenic protein (BMP) 8b, Bmp8R, and Natriuretic peptides (NP).  Bmp8bR was not 
upregulated in BAT of KO-PF mice (Appendix Figure 1.11).  Furthermore, the natriuretic 
peptide (NP) receptors were not different (Appendix Figure 1.11) at 10 or 20 weeks of 
age in KO-PF. 
 
Due to changes in the mitochondrial pathway in BAT of KO-PF mice (Chapter 2), we 
assayed other markers of lipolysis, oxidative phosphorylation and mitochondrial 
biogenesis.  These genes were unaltered (Appendix Figure 1.12, 1.13). 
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Appendix Figure 1.9. BAT FGF21 signaling is not increased in PF-KO mice.  (A) 
BAT Fgf21, β-klotho, and FgfR1 at 10 weeks of age (CON; n=6-9, AL; n=3-4, PF; n=5-
7). (B) BAT Fgf21, β-klotho, and FgfR1 at 20 weeks of age (CON; n=6, AL; n=3, PF; 
n=6-7). Error bars represent standard error of mean.  Blue bars represent KO-AL, red 
bars represent KO-PF.  No significance was found between groups by Student’s or 
Welch’s t-test accordingly.  Abbreviations: Fgf21; Fibroblast growth factor 21. FgfR1; 
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Appendix Figure 1.10. Adrenergic receptors are unchanged in BAT of KO-AL 
versus KO-PF.  Adrenergic receptor1a, 1d, b2, b3 expression at (A) 10 weeks (AL; n=4-
5, PF; n=5-7) and (B) 20 weeks (AL; n=2-3, PF; n=6-7).  Error bars represent standard 
error of mean.  Blue bars represent KO-AL, red bars represent KO-PF.  No significance 
was found between groups by Student’s or Welch’s t-test accordingly.  Abbreviations: 
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Appendix Figure 1.11.  BAT Natriuretic peptide receptors and bone morphogenic 
protein receptors are unchanged.  (A) NprA, NprC, and Bmp8bR at 10 weeks of age 
(AL; n=5, PF; n=7) and (B) NprA, NprC, and Bmp8bR at 20 weeks of age (AL; n=3, PF; 
n=6-7).  Error bars represent standard error of mean.  Blue bars represent KO-AL, red 
bars represent KO-PF.  No significance was found between groups by Student’s or 
Welch’s t-test accordingly.  Abbreviations: NprA/C; natriuretic peptide receptor A/C. 
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Appendix Figure 1.12.  BAT hormone sensitive lipase and lipoprotein lipase are 
unchanged in KO-AL versus KO-PF. Hsl and Lpl at (A) 10 weeks of age (AL; n=4, 
PF; n=5) and (B) 20 weeks of age (AL; n=1-3, PF; n=6-7) in BAT.  Error bars represent 
standard error of mean.  Blue bars represent KO-AL, red bars represent KO-PF.  No 
significance was found between groups by Student’s or Welch’s t-test accordingly.  
Abbreviations: Hsl; Hormone sensitive lipase. Lpl; Lipoprotein lipase.  Arbitrary units: 
relative expression to β-actin. 
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Appendix Figure 1.13. A subset of mitochondrial genes are not upregulated in KO-
PF mice compared to KO-AL. (A) Acadl, Acadm, Sod1, Sod2, Atp5g1, Pdk4, and Acc2 
at 10 weeks of age (AL; n=5, PF; n=7). (B) Acadl, Acadm, Sod1, Sod2, Atp5g1, Pdk4, 
and Acc2 at 20 weeks of age (AL; n=3-6, PF; n=7-12).  Error bars represent standard 
error of mean.  Blue bars represent KO-AL, red bars represent KO-PF.  No significance 
was found between groups by Student’s or Welch’s t-test accordingly.  Abbreviations: 
Acadl; Acyl-CoA dehydrogenase, long chain. Acadm; Acyl-CoA dehydrogenase, medium 
chain. Sod1/2; superoxide dismutase 1/2. Atp5g1; ATP synthase, H+ transporting, 
mitochondrial Fo complex, subunit C1. Pdk4; Pyruvate dehydrogenase kinase 4. Acc2; 
Acetyl-CoA carboxylase.  Arbitrary units: relative expression to β-actin. 
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Plasma catecholamine levels 
As discussed at length in the introduction section, norepinephrine (NE) activates BAT.  
KO-AL mice exhibited increased circulating NE (Appendix Figure 1.14), indicative of 
NE-resistance.  Paired-feeding normalized serum NE to control levels (Appendix Figure 
1.14), supporting the idea that paired-feeding enhances NE sensitivity. 
Appendix Figure 1.14.  Norepinephrine is normalized at 10 weeks of age in KO-PF 
mice.  CON 10, 20 weeks; n=5; KO-AL 10, 20 weeks; n=3, KO-PF 10, 20weeks; n=3.  
Error bars represent standard error of the mean.  Black bars represent control mice, blue 
bars represent KO-AL mice, red bars represent KO-PF mice.  Statistical significance was 
determined using One-way ANOVA on each age group, and then performing Student’s 




1. Watanabe M HS, Mataki C, Christoffolete MA, Kim BW, Sato H, Messaddeq N, 
Harney JW, Ezaki O, Kodama T, Schoonjans K, Bianco AC, Auwerx J. Bile acids induce 






	   168	  
APPENDIX II: The Epigastric Depot as a Source of Brown Adipose 
Tissue in Humans 
INTRODUCTION 
2.1% of the pediatric population is morbidly obesity (body mass index >40kg/m2) (1), 
and currently 17% of children 2-19 years of age are obese (2).  With the increased 
pediatric and adolescent obesity rates, bariatric surgery is being implemented at an earlier 
age to yield dramatic improvements in metabolic health status (3).  The current methods 
of bariatric surgery approved for use in the adolescent population are sleeve gastrectomy, 
adjustable gastric banding, and gastric bypass (4).  As seen with the adult population, 
bariatric surgery in the adolescent patient population yields drastic metabolic 
improvements, including improvements in glucose homeostasis post-surgery (5).   
 
Brown adipose tissue (BAT), once thought to be only relevant during infancy (as 
discussed in (6, 7)), is being investigated as a potential therapeutic target for obesity 
treatments.  It is known that infants contain classical BAT (cBAT) in the interscapular 
region (8), yet adult BAT is thought to be more of the beige origin (9, 10), with exception 
to the deep neck and perirenal regions (10-13).  Further complicating the field, brown and 
beige adipose tissue have been found to be co-expressed within white adipose tissue 
(WAT) depots (9).  It has been reported that there are depots of beige/brown adipose 
tissue within the epigastric region (14), therefore we collaborated with Dr. Jeffery 
Zitsman at Columbia University (an adolescent bariatric surgeon), to investigate this 
depot in obese and lean patients undergoing surgery.  Dr. Zitsman obtained adipose tissue 
samples from the epigastric region, a region widely accessible during laparoscopic 
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surgery, to determine 1) if BAT can be acquired in adolescent bariatric surgery patients in 
the epigastric region and 2) if BAT acquired from obese patients contain distorted 
mitochondrial structure and reduced thermogenic gene expression compared to lean 
individuals.   
 
METHODS 
Sample collection: Dr. Zitsman collected epigastric peritoneal adipose tissue, visceral 
adipose tissue, and falciform samples from obese patients undergoing bariatric surgery as 
well as lean patients undergoing appendectomy/cholecystectomies (Appendix Table 2.1).  
Samples were placed in either All Protect (Qiagen) for RNA analysis and stored in the -
20°C freezer, Z-Fix overnight and embedded in paraffin for immunohistochemical (IHC) 
staining, or 4% paraformaldehyde (PFA) + gluteraldehyde for 4 hours, 4% PFA 
overnight, and transferred to .1M phosphate buffer for electron microscopy by the 
Horvath Lab at Yale University. 
Gene expression analysis: First, we performed gene expression analysis on an array of 
markers of both white and brown adipose tissue; general BAT/beige markers include 
(15): Ucp1, Dio2, Pgc1α, β3-AR and Fgf21, white adipose tissue markers include: 
Leptin, and Asc-1.  Other genes used to differentiate brown adipose tissue, white adipose 
tissue, and beige adipose tissue (cBAT: Zic1, Prdm16, Cidea. Beige; Tmem26. 
cBAT/beige; Pat2, P2rx5. WAT; Hoxc9) (15) were not consistently present via qPCR 
analysis, and therefore could not be used as a readout. 
Immunohistochemical Analysis: Paraffin embedded sections were deparrifinized in 
xylene and rehydrated in ethanol.  Antigen retrieval was performed using 10mM sodium 
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citrate (pH 6).  Sections were blocked for endogenous peroxidase by hydrogen peroxide 
and blocked for non-specific staining using normal horse serum (NHS).  Sections were 
stained with 1:1600 dilution of UCP1 (ab10983) in 5% NHS overnight.  Sections were 
incubated in biotinylated secondary antibody.  Samples were incubated in Vectastain 
ABC Reagent (Vector Laboratory).  Samples were stained using 3, 3’ Diaminobenzidine 
(DAB) (Vector Labs), and counterstained with hematoxylin blue. 
 
RESULTS 
It has recently been described that many identifiable BAT depots in humans are primarily 
made up of beige adipocytes (10), and that beige adipocytes are heterogeneous in 
population (9).  We surveyed collected samples for markers of cBAT, beige, WAT, and 
general markers of BAT (see methods section). We found high variability between 
samples irrespective of the collected depot, and heterogeneity within the samples 
themselves in gene expression and protein levels, consistent with documented reports of 
the BAT found in humans (9).  
 
Visceral adipose tissue 
 Although it is promising that we acquired markers for brown adipocytes in our epigastric 
samples, many visceral adipose tissue also displayed signatures of BAT.  Of the 4 
visceral samples from obese patients shown in Appendix Figure 2.1, 4 out of 4 samples 
were positive for Leptin and 1 sample was positive for BAT as shown by increased Ucp1.  
The gene expression array from the visceral adipose tissue acquired from the lean patient 
was positive for BAT, as indicated by elevated Ucp1, Dio2, Ppargc1α, Fgf21, and 
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negligible Leptin and Asc-1 levels (Appendix Figure 2.2).  In addition, falciform samples, 
a ligament found around the liver and collected as a negative control, was positive for 
UCP1 via immunohistochemistry (IHC) and was positive for Ucp1 gene expression 
(Appendix Figure 2.3A, Appendix Table 2.2), indicating that the falciform sample was 
heterogeneous.  Although the falciform from lean patient 1 was relatively negative in 
expression of brown and white adipose tissue by qPCR (Figure 2.3B), the sample stained 
positive for UCP1 on IHC (Appendix Table 2.3), further supporting the claim that 
samples are not uniform. 
 
Epigastric adipose tissue 
As hypothesized, the epigastric region does contained BAT positive tissue.  As 
exemplified in Appendix Figure 2.4, most epigastric regions contained both Ucp1 and 
Leptin, further exemplifying the heterogeneity of the depot.  Of the samples shown, 2 out 
of 4 samples were positive for Ucp1, while 2 out of 4 samples were negative for Ucp1 
(Appendix Figure 2.4).  Interestingly, one sample was negative for Ucp1, yet positive for 
the BAT marker Ppargc1α (Appendix Figure 2.4C).  Additionally, 1 out of 4 of the 
epigastric samples was completely negative for BAT, and was positive for WAT.  
Occasionally, samples were collected from the same depot within an individual with a 
different approach to acquire the sample (anterior versus posterior approach).  These 
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Infant adipose tissue 
Within our sample population, some samples were infants.  As described in the literature 
(12), the samples acquired from the infant population had the highest levels of UCP1 
staining and multilocular lipid presence in the epigastric and visceral regions, indicative 
of cBAT (Appendix Figure 2.6).  Although gene expression in the visceral fat of infant 
patient 1 was negative for Ucp1 expression, IHC displayed increased UCP1 staining 
(Appendix Figure 2.6C,E) 
 
Lap band removal 
To determine whether epigastric adipose tissue after significant weight loss from an 
adjustable banding procedure induced increased BAT detection, we acquired epigastric 
and visceral samples from an individual undergoing band removal.  Both visceral and 
epigastric samples were negligible for Ucp1 and BAT markers (Appendix Figure 2.7). 
 
Discrepancies in the data 
Appendix tables 2.2 and 2.3 represent a population of samples that either resulted in good 
correlation between gene expression of BAT and IHC for UCP1, or poor correlation 
between the two.  From our findings, gene expression and UCP1 staining did not 
consistently match within a given sample, exemplifying heterogeneity of the tissue 
samples.  The inconsistencies found between gene expression and histological staining 
could be attributed to: 1) heterogeneity of the sample, thus splitting the sample in two for 
both histological and expression analysis does not result in two equal pieces of tissue, or 
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2) samples could have been two distinct samples acquired from the patient, but collect 
from the same general region. 
 
Mitochondrial structure from adipose samples 
To determine whether mitochondrial structure was distorted in the obese patients, we sent 
samples for electron microscopy (EM).  From the EM data we hoped to A) identify 
mitochondria within the fat depots deemed as “brown fat”, and B) determine whether 
mitochondria from obese subjects differ in structure compared to mitochondria from lean 
subjects.  Unfortunately, we were unable to detect mitochondria in our samples, possibly 
due to the sample heterogeneity.  As discussed previously, the samples acquired contain a 
mixed population of brown and white adipose tissue, contributing to the difficulty of 
finding mitochondria in a diluted environment.  
 
DISCUSSION 
From this small study, we have determined that it is possible to acquire BAT in the 
epigastric region in obese and lean adolescent individuals.  Although we are able to 
acquire BAT, this is an area of heterogeneity and therefore it is difficult to only acquire 
BAT.  Further sample analysis must be performed using reliable markers of beige, WAT 
and BAT, to determine the origin of fat recovered.  
 
To determine whether obesity distorts mitochondrial structure in humans, a mitochondrial 
isolation/purification step should be performed on each sample prior to EM.  This method 
will ensure that a population of BAT mitochondria is acquired for analysis.  This data 
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will elucidate whether the mitochondria in obese patients are distorted compared to the 
mitochondria of lean patients, and if overall structure can predict success to surgery.  
Additionally, having the ability to follow patients out longitudinally and acquire samples 
during gastric banding, as well as during band removal, will elucidate whether 
mitochondrial structure can be fixed in these depots after weight loss in humans (as we 
have seen in rodent models).  Although we did acquire tissue from one patient who 
received band removal, it is clear that we did not receive BAT positive tissue from this 
patient (Appendix Figure 2.7). 
 
FUTURE DIRECTIONS 
It is important to note that we used epigastric fat acquired from lean individuals 
undergoing laparoscopic appendectomy as a calibrator for the gene expression data.  For 
future studies, it will be important to acquire a reliable calibrator for the gene expression.  
Additionally, more tissue samples from lean (control) subjects need to be acquired and 
analyzed.  We found many promising samples that stained positive for UCP1, yet 
negative on qPCR.  Future studies looking at the macrophage marker, CD68, will need to 
be performed to elucidate whether the UCP1 IHC is an indicator of non-specific staining 
of macrophages.  Lastly, as mentioned above, future studies involving mitochondrial 
isolation must be performed to elucidate whether mitochondrial structure in brown 
adipose tissue in obese subjects morphologically differ from those of lean individuals. 
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FIGURES AND TABLES 
 
Appendix Table 2.1: Demographic of patient population.  Only a representative 






N Average BMI Notes 
Male Obese (Class 
II, III) 
15 1 50.9  
Female Obese (Class 
II, III) 
16.6 11 45.75  
Male Class I Obese 14 1 31.2 Collected 
initially as a 
control lean 
Female Overweight 22 1 29.8 Lap Band 
Removal 
Male Lean 17.5 1 20.4  
Female Lean  0   
Child Lean 6.5 2 N/A  
Male & 
Female Baby 
N/A 26 days 2 N/A  
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Scoring system for immunohistochemistry staining of epigastric adipose tissue, and 
negative control (visceral) tissue staining.  Key was used to identify correlation between 
UCP1 staining and gene expression data within a given sample as identified in Appendix 
Table 2.2, 2.3. 
 




























Lean Visceral Male 17.5 ++ + 
Lean Child 
1; H10 





Male 8 ++ + 
Appendix Table 2.2.  Good correlation between gene expression and UCP1 IHC 
within samples.  Samples from obese patients are represented in purple, samples from 
lean patients are represented in green. 
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Patient 2; H4 
Epigastric anterior 
approach 












Visceral Obese Female 15.6 +++ Neg 
Lean Patient 
1; H5 
Falciform Lean Male 17.5 ++ Neg 
Lean Child 
2; H15 
Epigastric Lean Male 5 + Neg 
Appendix Table 2.3.  Poor correlation between gene expression and UCP1 IHC 
within samples.  Samples from obese patients are represented in purple, samples from 


























Appendix Figure 2.1.  Gene expression analysis of visceral adipose tissue from obese 
patients.  Relative expression was normalized to the epigastric sample of the lean patient. 
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Appendix Figure 2.2: Gene expression analysis of visceral adipose tissue from a lean 





Appendix Figure 2.3.  Gene expression analysis of the falciform ligament from both 
an obese and lean patient.  Relative expression was normalized to epigastric sample of 
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Appendix Figure 2.4. Gene expression analysis of the epigastric depot from obese 
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Appendix Figure 2.5. Intra-patient variation in gene expression analysis of 
epigastric tissue.  (A,B) Epigastric depot acquired from obese patient 1.  (A) Sample 
acquired from the anterior approach, (B) sample acquired from the posterior approach.  
(C,D) Epigastric depot acquired from obese patient 2.  (C) Sample acquired from the 
posterior approach, (D) sample acquired from the anterior approach.  Relative expression 
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Appendix Figure 2.6. Gene expression analysis of the adipose depots from infants.  
(A,B) Epigastric gene expression data.  (C,D) Visceral gene expression data.  (E) UCP1 
IHC staining in visceral adipose tissue.  Relative expression was normalized to epigastric 
sample of the lean patient. 
  
	  
	   183	  
 
Appendix Figure 2.7. Gene expression from epigastric adipose depot after 
laparoscopic band removal.  Relative expression was normalized to epigastric sample 
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